A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1481
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PROs
Long Form : patient-reported outcomes
No. Year Title Co-occurring Abbreviation
2002 Prospective study designs in outcomes research: the case of migraine. ---
2002 The role of patient-reported outcomes in evaluating the quality of oncology care. ---
2003 Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. ERIQA, FDA, HRQL, ISOQOL, ISPOR, PhRMA-HOC, PRO
2004 Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. HRQL
2004 Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. CROs, HRQL, NMEs
2004 Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy. NSCLC
2005 Chronic venous disease: health status of a population and care impact on this health status through quality of life questionnaires. CVD, DS, QOL
2005 Item response theory and its applications to patient-reported outcomes measurement. IRT
2005 Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. GERD, HRQoL
10  2005 Patient-reported outcomes (PROs): an approach to evaluate treatment efficacy of Chinese medicine or integrative medicine. ---
11  2005 Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. DLQI, SF-36
12  2005 Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. iQoL, QOL
13  2005 The Health Assessment Questionnaire (HAQ). HAQ, HAQ-DI, PROMIS, VAS
14  2005 The state of patient-reported outcomes in atrial fibrillation : a review of current measures. AF, HRQoL
15  2005 [Regional comparison of patient-reported outcomes in Japanese cedar pollinosis]. JCP
16  2006 A promising method for identifying cross-cultural differences in patient perspective: the use of Internet-based focus groups for content validation of new patient reported outcome assessments. IFGs, PoC
17  2006 Integrating the patient's perspective into device evaluation trials. ---
18  2006 Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. CAM, RCTs
19  2006 More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments. IRT
20  2006 Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: considerations for future studies. EPC, LUTS, QOL
21  2006 Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment. OAB
22  2006 Quality of life assessment in clinical practice in haemophilia treatment. QOL
23  2006 Which instrument is more suitable to assess health-related quality of life: Nottingham Health Profile or Short-Form-36? HRQoL, NHP, SF-36, VAS
24  2007 Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial. DLQI, EQ-5D, HRQoL, PGA, SF-36
25  2007 Analysis and interpretation of results based on patient-reported outcomes. ---
26  2007 Applying item response theory and computer adaptive testing: the challenges for health outcomes assessment. CAT, DIF, IRT
27  2007 Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products. FDA, HRQL
28  2007 Commentary on "Health economics and the value of therapy in Alzheimer's disease." Report from the Alzheimer's Association Research Roundtable on patient-reported outcomes and dementia research. ---
29  2007 Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels. FDA, HRQoL
30  2007 Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier. EMEA, FDA
31  2007 Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the system. DFU, HIIP
32  2007 Ejaculatory latency vs. patient-reported outcomes (PROs) as study end points in premature ejaculation clinical trials. ---
33  2007 Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE. EDUCATE, PsA
34  2007 Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. ---
35  2007 Health-related quality of life measurement in symptom management trials. FDA, HRQoL
36  2007 How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL 4.0 Generic Core Scales. HRQoL, SCHIP
37  2007 Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. DLQI, SF-36, WPAI-SHP
38  2007 Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly. AS, EQ-5D, QOL
39  2007 Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. ---
40  2007 Interpreting and reporting results based on patient-reported outcomes. FDA
41  2007 Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. ---
42  2007 Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date. QOL
43  2007 Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model. HSRO, RTOG
44  2007 Patient's perception of exacerbations of COPD--the PERCEIVE study. COPD
45  2007 Patient-reported outcome instrument selection: designing a measurement strategy. ---
46  2007 Patient-reported outcomes in cystic fibrosis. CF
47  2007 Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. ---
48  2007 Patient-reported outcomes to support medical product labeling claims: FDA perspective. ---
49  2007 Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. DFO, EOS, ICT
50  2007 Quality of life, health status and clinical outcomes in Type 2 diabetes patients. T2DM
51  2007 Relationship of nasal congestion with sleep, mood, and productivity. AR
52  2007 Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. ---
53  2007 Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. PROMIS
54  2007 Symptom burden: multiple symptoms and their impact as patient-reported outcomes. HRQoL
55  2007 The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis. ---
56  2007 The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. FDA
57  2007 The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. IRT, NIH, PROMIS, PRSs, QIR, SCC, WHO
58  2007 Translating the science of patient-reported outcomes assessment into clinical practice. HRQoL
59  2007 Understanding the minimum clinically important difference: a review of concepts and methods. MCID
60  2007 Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions. ---
61  2007 What is sufficient evidence for the reliability and validity of patient-reported outcome measures? ---
62  2008 An assessment of patient-reported outcomes for men with erectile dysfunction: Pfizer's perspective. ED, EHS, SHIM
63  2008 Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis. ACR, HRQoL, RA
64  2008 Development of EMPRO: a tool for the standardized assessment of patient-reported outcome measures. ICC, ICC
65  2008 Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. IBS
66  2008 Electronic Diaries: Appraisal and Current Status. EMA
67  2008 Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. RCTs
68  2008 Factorial invariance of child self-report across age subgroups: a confirmatory factor analysis of ages 5 to 16 years utilizing the PedsQL 4.0 Generic Core Scales. HRQoL, MGCFA
69  2008 Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. HRQoL, PAH
70  2008 Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. DLQI, EQ-5D, HRQoL, MTX, VAS
71  2008 Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine. QOL
72  2008 Longitudinal factorial invariance of the PedsQL 4.0 Generic Core Scales child self-report Version: one year prospective evidence from the California State Children's Health Insurance Program (SCHIP). HRQoL, SCHIP
73  2008 Measuring the value of treatment to patients: patient-reported outcomes in drug development. ---
74  2008 Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial. ETN, RA
75  2008 Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment. EASE, HRU
76  2008 Patient-reported outcomes and the mandate of measurement. ---
77  2008 Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. DPI, MOS, pMDI, PSAM
78  2008 Patient-reported outcomes to evaluate surgery. HRQL
79  2008 Perspectives on patient-reported outcomes : content validity and qualitative research in a changing clinical trial environment. ---
80  2008 Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. HRQoL
81  2008 Psychometric equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish. DMS, HRQL, OAB-q, PPBC
82  2008 Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools. AMD, MacDQoL
83  2008 Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. RA, SRM, TJC
84  2008 Specific patient-reported outcome measures for Parkinson's disease: analysis and applications. HRQoL
85  2008 Systematic review of health-related quality of life measures for children with respiratory conditions. CF, HRQoL
86  2008 Taking PROs and patient-centered care seriously: incremental and disruptive ideas for incorporating PROs in oncology practice. ---
87  2008 The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. DPI, MOS, PSAM
88  2008 The prognostic significance of patient-reported outcomes in cancer clinical trials. PS
89  2008 The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia. BPI, FAACT, SF-36
90  2008 Using item banks to construct measures of patient reported outcomes in clinical trials: investigator perceptions. IRT
91  2008 [Patient reported outcomes. Relevance and application in ophthalmology]. ---
92  2009 A conceptual framework for patient-provider communication: a tool in the PRO research tool box. ---
93  2009 A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes. BoNTA, SPA
94  2009 Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. T1D, T2D
95  2009 Cognitive interviewing methodology in the development of a pediatric item bank: a patient reported outcomes measurement information system (PROMIS) study. PROMIS
96  2009 Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. ER, KHQ, OAB, PPBC, UUI
97  2009 Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. ER, HRQL, IIQ, OAB, OAB-q, PPBC, UPS, UUI
98  2009 Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. RA, RAID, RAID
99  2009 Linking measurement error to minimal important change of patient-reported outcomes. MIC, SEM
100  2009 Logistics of collecting patient-reported outcomes (PROs) in clinical practice: an overview and practical examples. CATs, ePRO, HRQoL
101  2009 Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. DLQI, EQ-5D, FACIT-F, QOL
102  2009 Optimal recall periods for patient-reported outcomes: challenges and potential solutions. ---
103  2009 Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin. MBS, OAB, OAB-q, PPBC, UUI, VAS
104  2009 Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. EQ-5D, HFS, HRQoL, OAHAs, SEs
105  2009 Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. PCS, PNET, STAI
106  2009 Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. EMEA, FDA, US
107  2009 Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment. ADHD, DCE
108  2009 Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. CI, IBS, IBS-C, IBS-D, OR
109  2009 Psychometric evaluation of the National Kidney Dialysis and Kidney Transplantation Study symptom checklist: reliability and validity. ESRD, NKDKTS
110  2009 Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial. ACR20, ANCOVA, CZP, HRQoL, LOCF, MCS, MTX, PBO, RA
111  2009 Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. ePRO, PRO
112  2009 Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial. CMEs, mBPI-e, OR-SDS
113  2009 Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. RA
114  2009 The applications of PROs in clinical practice: what are they, do they work, and why? MDTs
115  2009 The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder. MADRS-S, ROC
116  2009 The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. QOL
117  2009 Using patient-reported outcomes in clinical practice: challenges and opportunities. ---
118  2009 [Application of patient-reported outcomes in clinical research on therapeutic efficacy]. ---
119  2009 [Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)]. ---
120  2009 [Study on thirty patients with slow-transmission constipation treated by acupuncture and moxibustion]. PAC-QOL, QOL, STC
121  2010 Applying cognitive debriefing to pre-test patient-reported outcomes in older people with multiple sclerosis. MS
122  2010 Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. ---
123  2010 Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. ED, EF, IELT, PE
124  2010 Choosing patient-reported outcome measures for cancer clinical research--practical principles and an algorithm to assist non-specialist researchers. PROM
125  2010 Clinical studies with traditional Chinese medicine in the past decade and future research and development. QOL, TCM
126  2010 Communicating the results of randomized clinical trials: do patients understand multidimensional patient-reported outcomes? ---
127  2010 Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer. HRPC
128  2010 Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY). ---
129  2010 Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. BSC, CLAS, ECOG PS, FACT-An
130  2010 Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. BEACOPP, FFTF, HL, OS
131  2010 Evidence-based orthopedic surgery: is it possible? ---
132  2010 Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms. HRQL, ICIQ-SF, KHQ, OAB, TEAEs
133  2010 Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. ePRO
134  2010 Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. FDA
135  2010 Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. HA, LAF, SPA
136  2010 Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. GI
137  2010 Patient-reported outcomes (PROs) in dental clinical trials and product development: introduction to scientific and regulatory considerations. ---
138  2010 Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review. IAK, IT, ITA, PAK, PICO, PTA, QOL
139  2010 Patient-reported outcomes for acute graft-versus-host disease prevention and treatment trials. aGVHD, FDA, HCT
140  2010 Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial. ETN, HAQ, MTX
141  2010 Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. IRT, PROMIS
142  2010 PRO development: rigorous qualitative research as the crucial foundation. ---
143  2010 Psychometric evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness. mCRC, MID, PS
144  2010 Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. ---
145  2010 Single momentary assessments are not reliable outcomes for clinical trials. ---
146  2010 Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes. BOO, OAB, OAB-q, PPBC
147  2010 Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. HRQoL
148  2010 The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. DUMC, NSCLC
149  2010 The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. PROMIS
150  2010 Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants. EE, GERD, PAGI-QOL, PAGI-SYM, SEM
151  2010 Validity of average, minimum, and maximum end-of-day recall assessments of pain and fatigue. EOD
152  2011 A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. MDI, T2DM
153  2011 A comprehensive systematic review of the development process of 104 patient-reported outcomes (PROs) for physical activity in chronically ill and elderly people. PRO
154  2011 A systematic review of patient-reported and economic outcomes: value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus. HCOs, T2DM
155  2011 Application of the National Institutes of Health Patient-reported Outcome Measurement Information System (PROMIS) to mental health research. CAT, IRT, PROMIS
156  2011 Assessment of patient-reported outcomes in patients with melanoma. FACT-M
157  2011 Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial. CZP, MCIDs, MTX, NNT, PtGA, RA
158  2011 Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). CTCAE, PA, STAT
159  2011 Do dietary spices impair the patient-reported outcomes for stapled hemorrhoidopexy? A randomized controlled study. VAS
160  2011 Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate. DI, HAQ, HRQoL, MCID, MTX, RA, SF-36
161  2011 Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. IRS, LC, VAS
162  2011 Future of outcomes measurement: impact on research in medical rehabilitation and neurologic populations. NIH, PROMIS
163  2011 Health span or life span: the role of patient-reported outcomes in informing health policy. CHF
164  2011 Health-related quality of life in cystic fibrosis. HRQoL
165  2011 Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. ---
166  2011 Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. COMET, OR, VASs
167  2011 Interpreting patient-reported outcome results: US FDA guidance and emerging methods. SEALD
168  2011 Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). ---
169  2011 It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction. CER, PCORI, RWD
170  2011 Joint modeling of multiple longitudinal patient-reported outcomes and survival. ---
171  2011 Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis. CFQ-R, ESCF, HRQoL
172  2011 Measuring patient outcomes: a primer. ---
173  2011 Measuring patients' views: a bifactor model of distinct patient-reported outcomes in psychosis. SQOL
174  2011 Monitoring health-related quality of life in paediatric practice: development of an innovative web-based application. HRQoL
175  2011 PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study design. GLP-1, QOL, T2DM
176  2011 Patient reported outcomes in benign multiple sclerosis. EDSS
177  2011 Patient-reported outcome measures suitable to assessment of patient navigation. PROWG
178  2011 Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. EORTC, PCRT
179  2011 Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors. IBS
180  2011 Patient-reported outcomes in adult survivors with single-ventricle physiology. SVP
181  2011 Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs. RCTs
182  2011 Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. ICDs
183  2011 Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. LVAD
184  2011 Patient-reported outcomes in supportive care. NHI, PROMIS, QOL
185  2011 Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis. OMERACT, RA, RAID, SF
186  2011 Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen. AE, HAART, NRTIs, VL
187  2011 Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. ---
188  2011 Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. ---
189  2011 Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain. NRS
190  2011 Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients. HRQoL, MBC, PCM
191  2011 Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). NCI
192  2011 The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. PRO
193  2011 Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. FM, HRU
194  2011 Use of patient-reported outcomes in randomized, double-blind, placebo-controlled clinical trials. ---
195  2011 Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. AUC, EQ-5D, HTI, MCID, MDC, ODI, TLIF
196  2011 Validation of a bowel function diary for assessing opioid-induced constipation. BF-Diary, OIC, SBM
197  2011 Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials. CGI-I, MOS-Sleep, POMS, PSQ, RLS, RLSQoL
198  2011 Validation of the urinary sensation scale (USS). OAB, USS
199  2011 Validity of instruments to measure physical activity may be questionable due to a lack of conceptual frameworks: a systematic review. ---
200  2011 [Problems to pay attention to in taking patient-reported outcomes as clinical outcomes assessment]. ---
201  2012 A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. OA
202  2012 A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer. ---
203  2012 A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. ---
204  2012 Application of the dermatology life quality index in clinical trials of biologics for psoriasis. DLQI, QOL
205  2012 Capturing the patient perspective: patient-reported outcomes as clinical trial endpoints. PRO
206  2012 Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III). HR, mCRC, OS, PFS, VEGFR-TKI
207  2012 Characterization of hypoactive sexual desire disorder (HSDD) in men. HSDD, MDS, SCI-M, SDI, SDRDS, UCLA, USFDA
208  2012 Clinical outcomes in psoriatic arthritis: A systematic literature review. OMERACT, PsA
209  2012 Computerized adaptive testing--ready for ambulatory monitoring? CATs
210  2012 Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine. ---
211  2012 Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting. PROMIS
212  2012 Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden. ASTA, SCL
213  2012 Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. CCFA, CD, CDAI, IBD, IQR, MMAS, SCCAI, SD, SIBDQ, UC
214  2012 Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. 5-FU, GI
215  2012 Efficacy assessments in randomized controlled studies of acute therapy for hereditary angioedema. HAE, VAS
216  2012 Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. ESAs
217  2012 Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice. DLQI, SD, TSQM
218  2012 Expanding options for developing outcome measures from momentary assessment data. ---
219  2012 Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study. HRQoL
220  2012 Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. ISOQOL
221  2012 Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study. DAS28, HAQ-DI, MCIDs, PCS, TNFis
222  2012 Management of chronic rhinosinusitis. CRS, HRQL
223  2012 Measuring patient-reported outcomes in psychosis: conceptual and methodological review. ---
224  2012 Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies. HRQoL
225  2012 Patient reported outcomes in routine care: advancing data capture for HIV cohort research. ART, EHR
226  2012 Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis. CDAI, DAS28, RA
227  2012 Patient-reported outcomes (PROs): the significance of using humanistic measures in clinical trial and clinical practice. PRO
228  2012 Patient-reported outcomes after hepatic resection of colorectal cancer metastases. CRC
229  2012 Patient-reported outcomes in breast oncology: a review of validated outcome instruments. BCPT, MAS, MBROS, PBIS
230  2012 Patient-reported outcomes in idiopathic pulmonary fibrosis research. IPF
231  2012 Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study. BPH, BTX, IPSS, LUTS
232  2012 Patient-reported outcomes in rheumatoid arthritis. OMERACT, RA, RAID, RAPP-PI
233  2012 Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus. DPP-4, DTSQ, GLP-1, IWQOL-Lite, QOL, T2DM
234  2012 Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer. ---
235  2012 Physicians' Use of Patients' Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer Trials. EDD, QOL
236  2012 Pretransplantation assessments and symptom profiles: predicting transplantation-related toxicity and improving patient-centered outcomes. HCT
237  2012 Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. ET, QOL
238  2012 Recommendations for publication of cross-cultural validation studies of patient-reported outcomes (PROs) in Osteoarthritis and Cartilage. ---
239  2012 Screening for distress and unmet needs in patients with cancer: review and recommendations. ---
240  2012 Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia. FDA, GI
241  2012 The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring. CHES, ePRO
242  2012 The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer. HRQoL
243  2012 The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. DLCO, FVC, IPF, SE, SF-36, SGRQ-A, STEP-IPF
244  2012 Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes. HRQoL, TT
245  2012 Touchscreen questionnaire patient data collection in rheumatology practice: development of a highly successful system using process redesign. ---
246  2012 Usefulness of patients-reported outcomes in rheumatoid arthritis focus group. RA, SAI, TJCs
247  2012 Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient-reported outcomes assessments. GPCM, IRT
248  2012 Value of patient self-assessment in the diagnosis and monitoring of post-thrombotic syndrome: the Patient-Tracked Symptoms questionnaire. PTS
249  2012 Web-based patient-reported outcomes in drug safety and risk management: challenges and opportunities? AE
250  2012 [Patient-reported outcomes (PRO): historical profile, definitions, classifications and problems]. PRO
251  2012 [The benefits of using patient-reported outcomes in cancer treatment: an overview]. ---
252  2013 "Not just little adults": qualitative methods to support the development of pediatric patient-reported outcomes. EMA, HRQL
253  2013 A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis. AS, HAQ, ICC, NRSs, WPAI
254  2013 Achieving the Promise of Electronic Health Record-enabled Quality Measurement: a Measure Developer's Perspective. EHR
255  2013 Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis. GNDS, MS, MSNQ, MSWS
256  2013 Anxiety and depressive symptoms before and after total hip and knee arthroplasty: a prospective multicentre study. HOOS, KOOS, THA, TKA
257  2013 Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important? HRQoL, NSCLC
258  2013 Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010). EMA, FDA
259  2013 Characteristics and quality of life of patients presenting to cancer support centres: patient rated outcomes and use of complementary therapies. CIT, QOL
260  2013 Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective. CML, HRQoL, NMEs, TKI, US
261  2013 Cognitive reserve and patient-reported outcomes in multiple sclerosis. MS, NARCOMS
262  2013 Comparing Responsiveness of Six Common Patient-Reported Outcomes to Changes Following Autologous Chondrocyte Implantation: A Systematic Review and Meta-Analysis of Prospective Studies. ACI, CIs, IKDC, KOOS-Sports, mCMS, TP
263  2013 Cross-cultural adaptation and linguistic validation of age-group-specific haemophilia patient-reported outcome (PRO) instruments for patients and parents. HRQoL, PRO
264  2013 Cumulative response curves to enhance interpretation of treatment differences on the Self-Esteem And Relationship questionnaire for men with erectile dysfunction. CRCs, ED, SEAR
265  2013 Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff. PRO
266  2013 Development of a computer-adaptive version of the forgotten joint score. CAT, FJS
267  2013 Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. MFSAF, PGIC, PROMIS, QOL, TSS
268  2013 Efficacy, patient-reported outcomes (PROs), and tolerability of the changing therapeutic landscape in patients with metastatic prostate cancer (MPC): a systematic literature review. mPC, OS
269  2013 Factors influencing health-related quality of life after total hip replacement--a comparison of data from the Swedish and Danish hip arthroplasty registers. HRQoL, THR
270  2013 Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic celltransplantation. HCT, HRQoL
271  2013 Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. ---
272  2013 Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study. DAS, HAQ, HRQoL, MACTAR, MTX, RA, SF-36, UA, VAS
273  2013 Impaired quality of life, disability and mental health in Takayasu's arteritis. HADS, HCs, QOL, TAK
274  2013 Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. DMARDs, HADS, HAQ, RA, SF-36, WPAI
275  2013 Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study. DLQI, HRQoL, VAS
276  2013 Income and patient-reported outcomes (PROs) after primary total knee arthroplasty. OR, TKA
277  2013 Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. HRQL, MRC
278  2013 Incorporating patient-reported outcomes in total joint arthroplasty registries: challenges and opportunities. TJA
279  2013 Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study. CEE, EQ-5D, ESR, ETN, FACIT, HAQ-DI, LDA, MOS Sleep, MTX, PGA, RA, VAS, WPAI-RA
280  2013 Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes From Cancer Survivors (ePOCS) system. ePOCS, PROMs, response rate
281  2013 Integrating patient-reported outcomes into orthopaedic clinical practice: proof of concept from FORCE-TJR. ---
282  2013 Integration of clinical and patient-reported outcomes in surgical oncology. CONSORT, RCTs
283  2013 Literacy levels required to complete routinely used patient-reported outcome measures in rheumatology. ---
284  2013 Measuring clinical benefit: use of patient-reported outcomes (PRO) in primary brain tumor clinical trials. PRO, QOL
285  2013 Measuring outcomes in craniofacial and pediatric plastic surgery. CLP
286  2013 Measuring patient-reported outcomes in advanced gastric cancer. GC
287  2013 Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable? CTC, FDA, mCRPC, PCWG2, rPFS
288  2013 No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. EDSS, MS
289  2013 Operative diagnosis for revision total hip arthroplasty is associated with patient-reported outcomes (PROs). ADLs, CIs, OR, THA
290  2013 Patient engagement and reported outcomes in surgical recovery: effectiveness of an e-health platform. ESDP
291  2013 Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes. CDAI, LDA, mHAQ, RA
292  2013 Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review. HRQL, MOS-HIV
293  2013 Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review. ---
294  2013 Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. PRO-AEs, PROSPER
295  2013 Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). PPI, PREMs, PROMs
296  2013 Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. PCOR
297  2013 Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study. EQ-5D, IWQOL-Lite, VAS
298  2013 Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review. CF, HRQL
299  2013 Patient-reported outcomes in bariatric surgery: a systematic review of standards of reporting. RCTs, SF
300  2013 Patient-reported outcomes in gastroenterology: clinical and research applications. ---
301  2013 Patient-reported outcomes in meta-analyses--Part 1: assessing risk of bias and combining outcomes. ---
302  2013 Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers. ---
303  2013 Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. NF, NRS-11, QOL, REiNS
304  2013 Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. ISOQOL
305  2013 Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study. AVN, CI, OA, OR, RA, THA
306  2013 Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced population. CRC
307  2013 Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. HR, PFS
308  2013 Presence of fibromyalgia in patients with Takayasu's arteritis. FM, HADS, HAQ, TAK
309  2013 Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. OS
310  2013 Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study. ---
311  2013 Psychometric properties of patient-reported outcome measures for hip arthroscopic surgery. HAGOS, HOOS, HOS, MDC, MHHS, MIC
312  2013 Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes. ---
313  2013 Quality of postoperative pain management in American versus European institutions. ---
314  2013 Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32. AD, HRQoL, ROM, SNR
315  2013 Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study. DROs, PASS
316  2013 Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. CONSORT, EQUATOR, RCTs
317  2013 Screening for depression: only one piece of the puzzle. CKD
318  2013 Shock wave lithotripsy versus ureteroscopy for ureteral calculi: a prospective assessment of patient-reported outcomes. SFRs, SWL, UC, URS
319  2013 Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study. AIAAs, AIs, BBS, BCSs, BPI, FACIT-Fatigue, FACIT-Sp, FACT-B, FACT-GOG-Ntx, FR, HADS, QOL, SR, TUG
320  2013 The case for an international patient-reported outcomes measurement information system (PROMIS) initiative. CAT, IRT, PROMIS
321  2013 The early development phases of a European Organisation for Research and Treatment of Cancer (EORTC) module to assess patient reported outcomes (PROs) in women undergoing breast reconstruction. BRR, EORTC, HCPs, PROMs, UK
322  2013 The impact of newer atypical antipsychotics on patient-reported outcomes in schizophrenia. FDA
323  2013 The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis. CWC, GAS, HRQL, RQLQ
324  2013 Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. HRQoL, I-QOL, NDO, OAB-PSTQ, UI
325  2013 Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review. CML, HRQoL, TKIs
326  2013 Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopenia. ITP
327  2013 Usefulness of minimum clinically important difference for assessing patients with subaxial degenerative cervical spine disease: statistical versus substantial clinical benefit. MCID, MDC, NDI, PCS, SF-36, SR, VAS
328  2013 Using patient-reported outcomes (PROs) to compare the providers of surgery: does the choice of measure matter? ---
329  2013 Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention. AUC, SCNS-SF34
330  2013 Utilization of patient-reported outcomes as a step towards collaborative medicine. CF
331  2013 Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms. LUTS, OAB, SAGA
332  2014 A critical analysis of test-retest reliability in instrument validation studies of cancer patients under palliative care: a systematic review. HRQoL, PC
333  2014 An evidence-based determination of issues affecting quality of life and patient-reported outcomes in lung cancer: results of a survey of 660 patients. ---
334  2014 An overview of current trends and gaps in patient-reported outcome measures used in haemophilia. HRQL
335  2014 Arthroscopic labral reconstruction is superior to segmental resection for irreparable labral tears in the hip: a matched-pair controlled study with minimum 2-year follow-up. FAI, HOS, HOS-ADL, mHHS, NAHS, RECON, RESEC
336  2014 Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires. aBCC, BCCNS
337  2014 Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care. ACR, DAS28, EULAR, RA, SDAI
338  2014 Cerebrovascular disease is associated with outcomes after total knee arthroplasty: a US total joint registry study. CI, OR, TKA
339  2014 Challenges in measuring outcomes for caregivers of people with mental health problems. ---
340  2014 Changes and sex differences in patient reported outcomes in rheumatoid factor positive RA-results from a community based study. RA, RF
341  2014 Clinical benefit response in pancreatic cancer trials revisited. CBR
342  2014 Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis. DI, HAQ, MTX, PCS, PGA
343  2014 Correlation of patient-reported outcomes of sedation and sedation assessment scores in critically ill patients. SAS
344  2014 Defining response and non-response to treatment in patients with overactive bladder: a systematic review. OAB, UUI
345  2014 Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). PRO, PROMs
346  2014 Development and implementation of PROgmatic: A clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes. eCRFs, GRASS
347  2014 Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. GI, NIH
348  2014 Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. GI, GP, IBD, IBS, NIH, PROMIS, SSc
349  2014 Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales. MS
350  2014 Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences. MIDs
351  2014 Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study. CZP, DI, DLQI, HAQ, PsA, PsAQoL, SF-36, TNF
352  2014 Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. AT, CV, ED, FMD, IIEF, RP, UC
353  2014 Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. CLDQ-HCV, HCV, WP
354  2014 Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. IBD, PROMIS
355  2014 Exercise in the management of chronic back pain. CBOs
356  2014 Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. QOL
357  2014 Harmonizing and consolidating the measurement of patient-reported information at health care institutions: a position statement of the Mayo Clinic. ---
358  2014 Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing. CD, DHs, IBD-SES, ICF, LOT-R, PAM-13, PSQ
359  2014 Hip chondropathy at arthroscopy: prevalence and relationship to labral pathology, femoroacetabular impingement and patient-reported outcomes. FAI, HOOS
360  2014 Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. ALS, HRQoL, MBC, MDASI, WP, WPAI
361  2014 Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. HRQoL, MSAS, PediQUEST, PedsQL4.0
362  2014 Including patient-reported outcomes and patient-reported resource-use questionnaires in studies. ---
363  2014 Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease: From Clinical Trials to Daily Practice. COPD, VLABA
364  2014 Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines. AS03-TIV, MID
365  2014 Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries. PRO
366  2014 ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's. HRQoL, ITP
367  2014 Lack of patient-reported outcomes assessment in phase III breast cancer studies: a missed opportunity for informed decision making. ---
368  2014 Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia. GAS
369  2014 Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. HOOS, HOOS Pain, MCII, MCIIs, PASS, PASSs, THA
370  2014 Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. ERP, IQR
371  2014 New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. ---
372  2014 Outcomes reported in high-impact surgical journals. BJS, JACS, JAMA, QOL
373  2014 PAIN OUT: an international acute pain registry supporting clinicians in decision making and in quality improvement activities. EBM
374  2014 Patient expectations and patient-reported outcomes in surgery: a systematic review. QOL
375  2014 Patient reported outcomes as indicators of pediatric health care quality. ---
376  2014 Patient reported outcomes in pediatric oncology practice: suggestions for future usage by parents and pediatric oncologists. POs
377  2014 Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. HADS, HRQoL, SLE, WPAI
378  2014 Patient-reported outcome reference values for patients after kidney transplantation. HRQoL
379  2014 Patient-reported outcomes after neoadjuvant therapy for rectal cancer: a systematic review. ---
380  2014 Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhood. AIT, ARC
381  2014 Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. RTOG
382  2014 Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. FDA, IBD
383  2014 Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study. CLDQ-HCV, FACIT-F, IFN, SF-36, SOF, WPAI
384  2014 Patient-reported outcomes before and after treatment of major depressive disorder. Cohen's d, MDD, QOL
385  2014 Patient-reported outcomes for patients undergoing radical cystectomy: a prospective case-control study. BC, CC, HS, QOL, RC
386  2014 Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. CLDQ-HCV, FACIT-F, RBV, SF-36, SOF, SVR-12, WPAI-SHP
387  2014 Patient-reported outcomes in clinical trials of rare diseases. ---
388  2014 Patient-reported outcomes in obsessive-compulsive disorder. HRQoL, OCD, PROMs
389  2014 Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms. AIs, CES-D, EuroQol, HADS, HFRDI, NSABP, PSQI, RA, SA
390  2014 Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design. HRQoL, NSCLC, PROLUCA
391  2014 Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. QOL, SAQ
392  2014 Physiotherapists use of and perspectives on the importance of patient-reported outcome measures for shoulder dysfunction. ASES, DASH, OSS, REDCap, SPADI
393  2014 Promotion of Patient-Reported Outcome Label Claims Based on Nonprimary Endpoints. ---
394  2014 Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation. IBS-C, ICCs
395  2014 Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action! EC, QOL
396  2014 Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris. AEs, CBD, DLQI, PtGA, TSQM-9
397  2014 Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. QOL
398  2014 Remote collection of questionnaires. EMR, RA
399  2014 RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis. APBI, BrCa, mCathBrachy, pts, RTOG
400  2014 Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. AEs, CPET, FACT-B
401  2014 Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. PROMIS, SD
402  2014 Sex-Based Differences in the Clinical Presentation of Patients With Symptomatic Hip Labral Tears. VAS
403  2014 Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial. AE, HRQL, OAB, OAB-q, PPBC, UPS, UUI
404  2014 Symptom burden and comorbidities impact the consistency of responses on patient-reported functional outcomes. AM PAC CAT, NRS
405  2014 Systematic review of impact of lifestyle-modification programs on metabolic risks and patient-reported outcomes in adults with metabolic syndrome. LMPs, MetS
406  2014 Systematic review of non-invasive positive pressure ventilation for chronic respiratory failure. ALS/MND, CRF, DMD, NIPPV, OHS, RCTs, RTD
407  2014 The efficacy and safety of certolizumab pegol (CZP) in the treatment of active rheumatoid arthritis (RA): a meta-analysis from nine randomized controlled trials. ACR20, CZP, RA, RCTs
408  2014 The Equivalence of Remote Electronic and Paper Patient Reported Outcome (PRO) Collection. ICC, PRO
409  2014 The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C. DAAs, HCV, HRQoL, SMV, SOF
410  2014 The impact of upper facial lines and psychological impact of crow's feet lines: content validation of the Facial Line Outcomes (FLO-11) Questionnaire. CFL, UFL
411  2014 The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. HRQoL
412  2014 The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. RCTs
413  2014 The patient perspective on the Riata defibrillator lead advisory: a Danish nationwide study. ---
414  2014 The rationale for collecting patient-reported symptoms during routine chemotherapy. ASCO, CER, EHR
415  2014 The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. HER2, MBC, SystHERs
416  2014 Therapeutic affordances of social media: emergent themes from a global online survey of people with chronic pain. PWCP
417  2014 Use of cognitive interviews in the development of the PLUS-M item bank. CIs, PLUS-M
418  2014 Using patient-reported outcomes to assess and improve prostate cancer brachytherapy. QA/QI
419  2014 Vitrectomy with internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole. BCDVA, BCnVA, CI, FTMH, ILM, IPD, OR, RCTs
420  2014 Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA. AO, ATP III, BDI, HAQ, MetS, NCEP, PCS, RA, WC
421  2014 Web-based Comparative Patient-reported Outcome Feedback to Support Quality Improvement and Comparative Effectiveness Research in Total Joint Replacement. CMS, QI
422  2014 Which is the most useful patient-reported outcome in femoroacetabular impingement? Test-retest reliability of six questionnaires. FAI
423  2014 Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis. AS, BASDAI, BSA, DAS28, HAQ, PASI, PC, RA
424  2015 A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer. AS, AUASI, EPIC-26, MAX-PC, PSA, QOL, SF
425  2015 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines. CFL, FWS, GL
426  2015 A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol. EDSS, HRQoL, MFIS-5, MS, MSIP, MSQOL-54
427  2015 A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia. AEs, CAA, DA, EA, ESAs, Hb, RBC
428  2015 A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity. CD, CDAI
429  2015 Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. MS, QOL
430  2015 Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: a feasibility study. CIDs
431  2015 Agreement between touch-screen and paper-based patient-reported outcomes for patients with fibromyalgia: a randomized cross-over reproducibility study. CIs, CSQ, FIQ, FM, HSQs, ICCs, MDI, PDQ
432  2015 An eHealth Application in Head and Neck Cancer Survivorship Care: Health Care Professionals' Perspectives. ---
433  2015 An interactive portal to empower cancer survivors: a qualitative study on user expectations. EMR, SCP
434  2015 Analysis of associations between congenital heart defect complexity and health-related quality of life using a meta-analytic strategy. CHD, QOL
435  2015 Analysis of patient-reported outcomes from the LUME-Lung 1 trial: a randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer. NSCLC, OS, QOL
436  2015 Assessment of Patterns of Patient-Reported Outcomes in Adults with Congenital Heart disease - International Study (APPROACH-IS): rationale, design, and methods. CHD
437  2015 Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program. FSFI, SAQ, SSS, VAS
438  2015 Cancer patients' function, symptoms and supportive care needs: a latent class analysis across cultures. LCA, SCNS-SF34
439  2015 Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials. BYOD, ePRO, PRO
440  2015 Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. AUC, INX
441  2015 Collecting Patient-Reported Outcomes: Lessons from the California Joint Replacement Registry. CJRR, THA, TKA
442  2015 Communicating patient-reported outcome scores using graphic formats: results from a mixed-methods evaluation. ---
443  2015 Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. APR, FACT-C, NSABP, SSS
444  2015 Comparison of seven-day and repeated 24-hour recall of symptoms in the first 100 days after hematopoietic cell transplantation. HCT
445  2015 Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients. BCSS, QL
446  2015 Development and Evaluation of a Patient-Reported Outcome (PRO) Scale for Breast Cancer. PRO
447  2015 Development and validation of patient-reported outcomes scale for hypertension. ---
448  2015 Development of an ecological momentary assessment scale for appetite. EMA, PDA
449  2015 Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. MCS
450  2015 Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach. EMR
451  2015 Effect of complications within 90 days on patient-reported outcomes 3 months and 12 months following elective surgery for lumbar degenerative disease. MCID, MCS, NASS, ODI, PCS
452  2015 Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine. PDI, PHQ-9, QOL
453  2015 Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. DMARD-IR, FACIT-F, HAQ-DI, IVRS, MOS, PtGA, SF-36
454  2015 Equivalence of electronic and paper-based patient-reported outcome measures. ---
455  2015 Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis. MS
456  2015 Factors associated with long-term patient-reported outcomes after three-column osteotomies. ODI, SRS, three-COs
457  2015 Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. MDASI-HN
458  2015 Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register. MHAQ, PCS, PtGA, RA, SF-36, VAS
459  2015 Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned? ALL, AML, CLL, HRQoL, MDS, RCTs
460  2015 Health-related quality of life in caregivers of individuals with traumatic brain injury: development of a conceptual model. HRQoL, TBI
461  2015 How does a combined preoperative and postoperative rehabilitation programme influence the outcome of ACL reconstruction 2 years after surgery? A comparison between patients in the Delaware-Oslo ACL Cohort and the Norwegian National Knee Ligament Registry. ACLR, ADL, KOOS, NAR, NKLR
462  2015 How well are we measuring postoperative "recovery" after abdominal surgery? ICF
463  2015 Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. EPIC, FACT-P, NCCN, QOL, SF, UCLA-PCI
464  2015 Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. QOL
465  2015 Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis. AS, ASQoL, CZP, MCS, MOS, PCS, SF-36, SpA, SPI
466  2015 Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity. CZP, MCID, PtGA, RA, RADAI, RAPID3
467  2015 Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175patients. ---
468  2015 Incidence of Low Back Pain After Lumbar Discectomy for Herniated Disc and Its Effect on Patient-reported Outcomes. NRS-BP, ODI
469  2015 Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013). ---
470  2015 Integrating Patient-Reported Outcomes into Spine Surgical Care through Visual Dashboards: Lessons Learned from Human-Centered Design. HCD, HIT
471  2015 International multicentre psychometric evaluation of patient-reported outcome data for the treatment of Peyronie's disease. PD
472  2015 Minimally important difference estimates and methods: a protocol. MID
473  2015 Minimum clinically important difference in medical studies. MCID
474  2015 Obesity does not influence the outcome after unicompartmental knee arthroplasty. KOOS, KSS
475  2015 Outcome measures for antineutrophil cytoplasmic antibody-associated vasculitis. RCTs
476  2015 Outcome measures for Takayasu's arteritis. APRs, TAK
477  2015 Overcoming Organizational Challenges of Integrating Patient-Reported Outcomes in Oncology Clinical Trials. ---
478  2015 PAIN OUT: the making of an international acute pain registry. ---
479  2015 Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care. CDAI, PASS, PRO-CLARA, RA, RAID, ROAD, ROC
480  2015 Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology. EULAR, PsAID
481  2015 Patient reported outcomes and patient empowerment in clinical genetics services. CGS, PROMs
482  2015 Patient reported outcomes for diabetic peripheral neuropathy. DPN
483  2015 Patient Reported Outcomes in Adult Spinal Deformity Surgery: ABibliometric Analysis. ASD, LOE, ODI, SF-36, SRS, VAS
484  2015 Patient satisfaction with double-door laminoplasty for cervical compression myelopathy. JOACMEQ
485  2015 Patient-Reported Outcome Measures in Individuals With Chronic Ankle Instability: A Systematic Review. CAI, HRQoL
486  2015 Patient-reported outcome measures in vascular surgery. ---
487  2015 Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial. SIQ, STR, TSQ
488  2015 Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study. QOL
489  2015 Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. COPD
490  2015 Patient-reported outcomes and therapeutic affordances of social media: findings from a global online survey of people with chronic pain. PWCP
491  2015 Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. RA
492  2015 Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. CRT, DLQI, HRQL
493  2015 Patient-reported outcomes in core domain sets for rheumatic diseases. ---
494  2015 Patient-reported outcomes in drug development for hematology. ---
495  2015 Patient-Reported Outcomes in Elective Cranial Neurosurgery. CI, mRS, OR, PROMs
496  2015 Patient-reported outcomes in heart failure: existing measures and future uses. ---
497  2015 Patient-Reported Outcomes in Latin America: Implementation in Research and Role in Emerging HTA Systems. HTA, LATAM
498  2015 Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making. CRC, RCTs
499  2015 Patient-reported outcomes to initiate a provider-patient dialog for the management of hip and knee osteoarthritis. OA
500  2015 Pelvic radiotherapy and sexual function in women. FSD, QOL, RCTs
501  2015 Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients. ---
502  2015 Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. CONSORT, PRORQS, RCTs
503  2015 Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice. ---
504  2015 Prediction model for outcome after low-back surgery: individualized likelihood of complication, hospital readmission, return to work, and 12-month improvement in functional disability. AUC, ODI
505  2015 Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial. 3D-CRT, FACE, Gy, IIEF, IMRT, RT, RTOG
506  2015 Problem areas identified as important to older adults with lumbar spinal stenosis. ESIs
507  2015 PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events. ---
508  2015 Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial. IL, PTC, QOL, UC
509  2015 Psychosocial/survivorship issues in breast cancer: are we doing better? ---
510  2015 Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic. QOL
511  2015 Quality of life aspects in the management of thyroid cancer. QOL
512  2015 Quality of Life Assessment in Sarcoidosis. HRQL
513  2015 Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study. 6MWT, ASCT, CPET, MM
514  2015 Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. IBD PRTI, IBDQ, UC
515  2015 Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer. AS, EBRT, GI, RT
516  2015 Reporting outcomes of definitive radiation-based treatment for esophageal cancer: a review of the literature. RCTs
517  2015 Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012). CROs, EMA, EPAR, LROs, MA, PEs
518  2015 Searching for success: Development of a combined patient-reported-outcome ("PRO") criterion for operationalizing success in multi-modal pain therapy. PRO
519  2015 Sense of coherence in young people with congenital heart disease. CHD, SOC
520  2015 Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis. MF, OS
521  2015 Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies. AEs, PBO, PR, RGT, SMV, SVR12
522  2015 Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes. HCV, HIV
523  2015 Study on the consistency of doctor-report outcomes and patient-report outcomes in symptoms of traditional Chinese Medicine: a small sample size trial in diabetics. DROs, NRS, VAS
524  2015 Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer. EGFR, NSCLC, PFS, QOL
525  2015 Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. ---
526  2015 Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study. PediQUEST, PQ-MSAS
527  2015 Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. RCTs
528  2015 Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens. CHC, HRQoL
529  2015 Tailoring interventions: identifying predictors of poor asthma control. ---
530  2015 The association of comorbid conditions with patient-reported outcomes in Veterans with hip and knee osteoarthritis. OA, SACQ
531  2015 The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). AEs, CSDs, FACT-L, Gr, LCSS
532  2015 The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials. HRQoL, OAB, OAB-q, PPBC
533  2015 The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments. OML
534  2015 The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review. FPS
535  2015 The need for patient-centred clinical research in idiopathic pulmonary fibrosis. IPF
536  2015 The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review. EOL, HRQoL, RCTs
537  2015 The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. ---
538  2015 Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial. DI, FACIT-F, HAQ, MOS, PtGA, RA, TNFi
539  2015 Training clinicians in how to use patient-reported outcome measures in routine clinical practice. ---
540  2015 Traumatic atlantooccipital dislocation: comprehensive assessment of mortality, neurologic improvement, and patient-reported outcomes at a Level 1 trauma center over 15 years. AOD, ASIA, ISS, NDI, NRS
541  2015 Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials. IFN, LDV/SOF, RBV
542  2015 Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. CTCAE, HRQoL
543  2015 Using patient-reported outcomes in routine practice: three novel use cases and implications. ---
544  2015 Utilizing Multidimensional Computer Adaptive Testing to Mitigate Burden With Patient Reported Outcomes. CAT, IRT, MCAT, MIRT, PROMIS
545  2015 Validation of Portuguese-translated computer touch-screen questionnaires in patients with rheumatoid arthritis and spondyloarthritis, compared with paper formats. ASQoL, BASDAI, BASFI, HAQ, ICC, RA, SF-36, VAS
546  2015 Variation in Patient-reported Outcomes Across Hospitals Following Surgery. BQL, HALex, HRQoL
547  2015 What clinimetric evidence exists for using hip-specific patient-reported outcome measures in pediatric hip impingement? ---
548  2015 What is the role of mental health in primary total knee arthroplasty? KS, ROM, TKA
549  2015 [Development and Evaluation of GS-SF for Gastric Stuffiness (Wei PI) Patients Based on Item Response Theory, Computerized Adaptive Testing, and Data Simiuation]. CAT, ICC, IIC, IRT
550  2015 [Patient-centredness in health services research]. QOL
551  2016 'Trial Exegesis': Methods for Synthesizing Clinical and Patient Reported Outcome (PRO) Data in Trials to Inform Clinical Practice. A Systematic Review. PRO, RCTs
552  2016 A clinical perspective on electronically collecting patient-reported outcomes at the point-of-care for overactive bladder. OAB
553  2016 A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms. MPNs
554  2016 A Systematic Review of Patient-reported Outcomes in Randomized Controlled Trials of Unplanned General Surgery. RCTs
555  2016 Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens. CLDQ-HCV, FACIT-F, HCV, RBV, SF-36, SOF, WPAI
556  2016 Advantages and psychometric validation of proximal intensive assessments of patient-reported outcomes collected in daily life. PIA
557  2016 Agreement between personally generated areas of quality of life concern and standard outcome measures in people with advanced cancer. PGI, QOL
558  2016 Ambulatory and diary methods can facilitate the measurement of patient-reported outcomes. ---
559  2016 An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens. RBV
560  2016 Are Patient-reported Outcomes Correlated With Clinical Outcomes After Surgery?: A Population-based Study. BQL, HALex
561  2016 Arthroscopic reconstruction of the Ligamentum Teres: a case series in four patients with connective tissue disorders and generalized ligamentous laxity. LT
562  2016 ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis. ASAS40, ASDAS-CII, HAQ-S, nr-axSpA, PCS
563  2016 Assessing Patient Reported Outcomes Measures via Phone Interviews Versus Patient Self-Survey in the Clinic: Are We Measuring the Same Thing? FTE, ODI, VAS-BP, VAS-LP
564  2016 Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases: A Systematic Review of the Literature (the PROCHID Study). ---
565  2016 Assessing the Effects of Participant Preference and Demographics in the Usage of Web-based Survey Questionnaires by Women Attending Screening Mammography in British Columbia. CI, SMPBC
566  2016 Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis. DAS28
567  2016 Baseline Patient-Reported Outcomes Correlate Weakly With Radiographic Parameters: A Multicenter, Prospective NIH Adult Symptomatic Lumbar Scoliosis Study of 286 Patients. ASLS, LC, ODI, PI-LL, PT, SVA
568  2016 Challenges and Opportunities in Using Patient-reported Outcomes in Quality Measurement in Rheumatology. ---
569  2016 China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design. AMI, PEACE
570  2016 Collecting, Integrating, and Disseminating Patient-Reported Outcomes for Research in a Learning Healthcare System. ---
571  2016 Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study. ADAs, AS, ASAS, BASDAI, BASFI, PK, RP
572  2016 Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability. ISBS, RA, TNF
573  2016 Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort. BoM, CR, MF, RT, SF
574  2016 Defining a Research Agenda for Patient-Reported Outcomes in Surgery: Using a Delphi Survey of Stakeholders. ---
575  2016 Design and feasibility of integrating personalized PRO dashboards into prostate cancer care. HRQoL
576  2016 Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review. CINAHL, PRO
577  2016 Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. HCPs
578  2016 Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire: a new patient-reported outcome instrument for PAH. PAH, PAH-SYMPACT
579  2016 Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort. ASDAS, axSpA, BMI, CRP, SPACE
580  2016 Does Obesity Correlate With Worse Patient-Reported Outcomes Following Elective Anterior Cervical Discectomy and Fusion? ACDF, SF-12
581  2016 Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome. OAB, OABSS
582  2016 Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term? HRQoL, PtGA, RA
583  2016 Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). AD
584  2016 Editorial: Using Patient-Reported Outcome Measures in Gastroenterology: PROMISed Land or Road to Nowhere? GI, PROMIS
585  2016 Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection. HCV, PF, SVR12
586  2016 Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. COPD, FDCs, LABAs, LAMAs, UMEC/VI
587  2016 EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. eHealth, IBD
588  2016 Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life. STAR
589  2016 Electronic Patient-Reported Outcomes: The Time Is Ripe for Integration Into Patient Care and Clinical Research. ePRO
590  2016 Engaging stakeholders to improve presentation of patient-reported outcomes data in clinical practice. ---
591  2016 Establishing Equivalence of Electronic Clinician-Reported Outcome Measures. eClinROs
592  2016 Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits. EPIC
593  2016 Evaluation of quality of life using a tablet PC-based survey in cancer patients treated with radiotherapy: a multi-institutional prospective randomized crossover comparison of paper and tablet PC-based questionnaires (KROG 12-01). ICCs
594  2016 Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders. GI, Hgb, IDA
595  2016 Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities. ---
596  2016 Gaze stabilization and dynamic visual acuity in people with multiple sclerosis. DVAT, GST, MS, VOR
597  2016 Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: What makes a pro picture worth a thousand words? PRO
598  2016 HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). HD, HRQoL
599  2016 Healthcare Professionals' Preferences and Perceived Barriers for Routine Assessment of Patient-Reported Outcomes in Pediatric Oncology Practice: Moving Toward International Processes of Change. HCPs
600  2016 Impact of National Institutes of Health Gastrointestinal PROMIS Measures in Clinical Practice: Results of a Multicenter Controlled Trial. DISQ, GI, NIH, PROMIS
601  2016 Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus. ILD, PFTs, PH, PPO, SLE, SLS
602  2016 Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients. ESS, FSS, HTN, PAP, PHQ-9, RHTN, SDB
603  2016 Independent predictors of reliability between full time employee-dependent acquisition of functional outcomes compared to non-full time employee-dependent methodologies: a prospective single institutional study. FTE, ODI
604  2016 Interpreting patient-reported outcomes from clinical trials in COPD: a discussion. ---
605  2016 Is more lordosis associated with improved outcomes in cervical laminectomy and fusion when baseline alignment is lordotic? CSA, CSM, MCS, PCS, SF-12, SVA
606  2016 Is quality of life following hip arthroscopy in patients with chondrolabral pathology associated with impairments in hip strength or range of motion? HOOS-Q
607  2016 Is the use of antidepressants associated with patient-reported outcomes following total hip replacement surgery? HRQoL, PROMs, THR, VAS
608  2016 Italian-validated questionnaires for pelvic floor disorders: on behalf of the Italian Society of Urodynamics. PFDs
609  2016 Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases. LSDs
610  2016 Long-term results of oncoplastic breast surgery with latissimus dorsi flap reconstruction: a pilot study of the objective cosmetic results and patient reported outcome. ---
611  2016 Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey. PRO
612  2016 MASTERS-D Study: A Prospective, Multicenter, Pragmatic, Observational, Data-Monitored Trial of Minimally Invasive Fusion to Treat Degenerative Lumbar Disorders, One-Year Follow-Up. AEs, DLD, MILIF, ODI, TFA, TSR
613  2016 Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease. anti-TNF, CD, IBD, UC
614  2016 Methodologic Considerations for Collecting Patient-reported Outcomes from Unselected Surgical Patients. ---
615  2016 Mode of administration does not cause bias in patient-reported outcome results: a meta-analysis. MoA
616  2016 Muscle function is associated with future patient-reported outcomes in young adults with ACL injury. ACL, ARS, KANON, KOOS, KOOS Q3
617  2016 Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-alpha Gene Expression in Peripheral Blood Mononuclear Cells. IL-1 beta, IL-6, mRSS, SF-36, SHAQ, SSc, TNF-alpha
618  2016 Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). FLI, HRQoL, NAFLD, NHANES
619  2016 Outcomes After Patch Use in Rotator Cuff Repair. ADLs
620  2016 Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science. HRQoL, mCRPC
621  2016 Patient Factors That Influence Decision Making: Randomization Versus Observational Nonoperative Versus Observational Operative Treatment for Adult Symptomatic Lumbar Scoliosis. ASLS, OBS-NS, OBS-S, ODI, RAND, SRS
622  2016 Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. PGA, RA
623  2016 Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use? COPD
624  2016 Patient Reported Outcomes (PROs) are sensitive outcome-variables in patients with chronic pain: Importance of self-efficacy. ---
625  2016 Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials. PRO, T2D
626  2016 Patient reported outcomes after incisional hernia repair-establishing the ventral hernia recurrence inventory. ---
627  2016 Patient-Reported Outcome Assessments as Endpoints in Studies in Infectious Diseases. OAs
628  2016 Patient-Reported Outcome Instruments for Surgical and Traumatic Scars: A Systematic Review of their Development, Content, and Psychometric Validation. POSAS, PRISM, PSAQ
629  2016 Patient-Reported Outcome Measurement in Clinical Dermatological Practice: Relevance and Feasibility of a Web-Based Portal. ---
630  2016 Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data. ---
631  2016 Patient-Reported Outcome Measures: How Do Digital Tablets Stack Up to Paper Forms? A Randomized, Controlled Study. ---
632  2016 Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned. CONSORT, ESMO-MCBS, FDA, PRO
633  2016 Patient-reported Outcomes After Conservative or Surgical Management of Recurrent and Chronic Complaints of Diverticulitis: Systematic Review and Meta-analysis. CI, QOL
634  2016 Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer. AIs, CI, HR, VAS
635  2016 Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. HCT, OS, PSQI, SES
636  2016 Patient-reported outcomes and their predictors at 2- and 3-year follow-up after immediate latissimus dorsi breast reconstruction and adjuvant treatment. ALD, EORTC, FACT-B, HADS, LDI
637  2016 Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis. MTX, RA, s.c
638  2016 Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir. CHC, IFN, LDV, RBV, SOF
639  2016 Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). AEs, FDA
640  2016 Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation. HNC, ISOQOL, PROMOTION, RCTs
641  2016 Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma. HCC, HRQoL
642  2016 Patient-reported outcomes in lupus clinical trials with biologics. QOL, SLE
643  2016 Patient-reported outcomes in metastatic castration-resistant prostate cancer. mCRPC
644  2016 Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges. ---
646  2016 Patient-Reported Outcomes in Rheumatoid Arthritis. RA
647  2016 Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. ---
648  2016 Patient-reported outcomes in the Swedish National Quality Registers. PREM, PROMs
649  2016 Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review. PMR, RCTs
650  2016 Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma. BV, HL, HRQoL, R/R, sALCL
651  2016 Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens. ---
652  2016 Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. NF, PROMIS, REiNS
653  2016 Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study. ---
654  2016 Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. CLDQ-HCV, FACIT-F, HCV, WPAI
655  2016 Patient-reported outcomes with the beta3 -adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder. ER, OAB, OAB-q, PPBC, TS-VAS, WPAI-SHP
656  2016 Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). BMT CTN, HCT, PCS, SF-36
657  2016 Patient-Reported Safety Events in Chronic Kidney Disease Recorded With an Interactive Voice-Inquiry Dial-Response System: Monthly Report Analysis. CKD, ER, IVRDS, SKC
658  2016 Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer. MDASI, NSCLC, VATS
659  2016 Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort. DAS28-3v, EMIR-court, HAQ, RA, RAPID3, SF36
660  2016 Plate fixation of midshaft clavicular fractures: patient-reported outcomes and hardware-related complications. DASH, ORIF
661  2016 Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model: A Simulation Study. CTT, GRM
662  2016 Predictors of the efficacy of epidural steroid injections for structural lumbar degenerative pathology. AUC, BP, LESI, LP, MCID, ODI, SF
663  2016 PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study. EORTC, HCPs, HRQoL, MDASI
664  2016 Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial. CI, HR, ORR, OS, PFS, PPR, PROC, SPR
665  2016 Provider perceptions of the value of same-day, electronic patient-reported measures for use in clinical HIV care. ---
666  2016 Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations. PROMIS F-SF
667  2016 Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial. CI, MBC, QOL
668  2016 Quantifying clinical change: discrepancies between patients' and providers' perspectives. KCCQ
669  2016 RADAI-5 and electronic monitoring tools. RA
670  2016 Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era. GAS
671  2016 Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. IMPT
672  2016 Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naive patients with rheumatoid arthritis. ACR70, LDA, MTX, RA
673  2016 Reliability of patient-reported outcomes in rheumatoid arthritis patients: an observational prospective study. ICCs, PGA, SDDs
674  2016 Remifentanil and worse patient-reported outcomes regarding postoperative pain management after thyroidectomy. ---
675  2016 Repeated measures analysis of patient-reported outcomes in prostate cancer after abiraterone acetate. FACT-P, HRQoL, mCRPC, PCS, PMM, TOI
676  2016 Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis. ICF, MTX, RA
677  2016 Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials. GTs, HCV, RBV, SOF, SOF/VEL
678  2016 Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes. BMI, CI, OR
679  2016 Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial. FACIT-F, HAQ-DI, MCID, PtGA, RA, RCT, SF-36
680  2016 Self-rated health in patients with rheumatoid arthritis is associated with health-related quality of life but not with clinical variables. CCI, CI, HAQ, HRs, NHP, QOL, RA, SRH
681  2016 Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus. LDV/SOF, RBV
682  2016 Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial. HCV, SOF, SVR, VEL
683  2016 Standards for Clinical Trials in Male and Female Sexual Dysfunction: II. Patient-Reported Outcome Measures. ---
684  2016 Study Design and Cohort Description of DEFIB-WOMEN: A National Danish Study in Patients with an ICD. ICD
685  2016 Surgical Resection of Intradural Extramedullary Spinal Tumors: Patient Reported Outcomes and Minimum Clinically Important Difference. EQ-5D, HTI, IDEM, MCID, NRS, SF-12, SRMs
686  2016 Symptom Resolution and Patient-Perceived Recovery Following Ankle Arthroplasty and Arthrodesis. ADL
687  2016 Systematic collection of patient reported outcome research data: A checklist for clinical research professionals. CRPs
688  2016 The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design. AMI, PCI, PEACE
689  2016 The effect of EHR-integrated patient-reported outcomes on satisfaction with chronic pain care. EHR, IT, PCPs
690  2016 The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research. HRQoL
691  2016 The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study. LDV/SOF, RBV
692  2016 The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols. RCTs
693  2016 The Prognostic Value of Patient-Reported Outcome Data in Patients With Colorectal Hepatic Metastases Who Underwent Surgery. CI, CRC, HR, QLQ
694  2016 The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it. PROSSES
695  2016 The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual. ---
696  2016 The usefulness of a mobile device-based system for patient-reported outcomes in a spine outpatient clinic. mobile system, PRS
697  2016 The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors. CML, QOL, TKIs
698  2016 Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis. SF-36
699  2016 Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study. DLQI, HRQoL, OPT
700  2016 Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial. FACIT-F, HAQ-DI, MTX, PCS, PtGA, SF-36
701  2016 Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer. SCPs
702  2016 Using Patient Reported Outcomes in Oncology Clinical Practice. ---
703  2016 Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis. DI, DLQI, HAQ, MTX, PCS, PsA, TNF
704  2016 Validity of Single-Item Patient-Rated Outcomes in Adolescent Football Athletes With Concussion. HIT-6, MFS
705  2016 www.common-metrics.org: a web application to estimate scores from different patient-reported outcome measures on a common scale. BDI, CES-D, EAP, IRT, ML, WLE
706  2017 "Am I normal?" The Wishes of Patients With Lymphoma to Compare Their Patient-Reported Outcomes With Those of Their Peers. HRQoL
707  2017 A bibliometric study of the scientific publications on patient-reported outcomes in rheumatology. ---
708  2017 A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma. STS
709  2017 A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus. CLE, HRQoL
710  2017 Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction. AA, mCRPC, PSA
711  2017 ACL Return to Sport Guidelines and Criteria. ACL, ACLR, FTA
712  2017 Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study. ADA, ASDAS-CRP, BASDAI, BASFI, BASMI, CDAI, ES, HAQ, HRQoL, IBDQ, PGA, pMayo, SF-36, TNF
713  2017 Additional Contribution of the Malnutrition-Inflammation Score to Predict Mortality andPatient-Reported Outcomes as Compared With Its Components in a Cohort of African Descent Hemodialysis Patients. HRQoL, MHD, MIS, PROHEMO
714  2017 Age is not a barrier to good outcomes after varicose vein procedures. CEAP, VCSS, VQI, VVR
715  2017 An analysis from the Quality Outcomes Database, Part 1. Disability, quality of life, and pain outcomes following lumbar spine surgery: predicting likely individual patient outcomes for shared decision-making. ASA, BP, LP, NRS, ODI, QOL
716  2017 Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations. HRQoL, KOOS, MIDs, WOMAC
717  2017 Appraisal assessment in patient-reported outcome research: methods for uncovering the personal context and meaning of quality of life. MS, QOL
718  2017 Are community-based nurse-led self-management support interventions effective in chronic patients? Results of a systematic review and meta-analysis. OROs
719  2017 Arthroscopic Capsular Plication and Labral Seal Restoration in Borderline Hip Dysplasia: 2-Year Clinical Outcomes in 55 Cases. ---
720  2017 Arthroscopic Labral Base Repair in the Hip: 5-Year Minimum Clinical Outcomes. HOS-SSS, LBR, mHHS, NAHS, VAS
721  2017 Arthroscopic Reconstruction of Segmental Defects of the Hip Labrum: Results in 22 Patients With Mean 2-Year Follow-Up. THA
722  2017 Arthroscopic Treatment of Labral Tears of the Hip in Adolescents: Patterns of Clinical Presentation, Intra-articular Derangements, Radiological Associations and Minimum 2-Year Outcomes. HA
723  2017 Assessment of patient-reported outcomes in retinal diseases: a systematic review. ---
724  2017 Assessment of the Minimum Clinically Important Difference in the Timed Up and Go Test After Surgery for Lumbar Degenerative Disc Disease. MCID, TUG Test
725  2017 Association between Continuity of Care and Health-Related Quality of Life. COC, MCC
726  2017 Association between pain sensitivity in the hand and outcomes after surgery in patients with lumbar disc herniation or spinal stenosis. ---
727  2017 Association Between the Single Assessment Numeric Evaluation and the Western Ontario and McMaster Universities Osteoarthritis Index. OA, SANE, WOMAC
728  2017 Association of Fat Grafting With Patient-Reported Outcomes in Postmastectomy Breast Reconstruction. AMD
729  2017 Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population. axSpA, BAS-G, BASDAI, BASFI, HAQ, SF-36
730  2017 Associations Between Relative Value Units and Patient-Reported Back Pain and Disability. RVUs
731  2017 Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data with Applications to Cancer Clinical Trials. CPO, DIC, LPML
732  2017 Bayesian multivariate augmented Beta rectangular regression models for patient-reported outcomes and survival data. ---
733  2017 Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes. BMI, CI, OR
734  2017 Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study. ---
735  2017 Cancer patients' control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center. DCP
736  2017 Case Studies from the Clinic: Initiating and Implementing Patient-Reported Outcome Measures. PRO
737  2017 Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. CI, CIBMTR, FACT-BMT, HCT, OR
738  2017 Changes in the use of end points in clinical trials for elderly cancer patients over time. ---
739  2017 Child and parent preferences for graphical display of patient-reported outcome data. ---
740  2017 Clinical Outcomes of Hip Arthroscopic Surgery in Patients With Femoral Retroversion: A Matched Study to Patients With Normal Femoral Anteversion. HOS-SSS, mHHS, NAHS, VAS
741  2017 Collection of daily patient reported outcomes is feasible and demonstrates differential patient experience in chronic kidney disease. CKD, GWB, PROMs
742  2017 Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY). HRQoL, MIDs, OAB
743  2017 Commonly Used Patient-Reported Outcomes Do Not Improve Prediction ofCOPD Exacerbations: A Multicenter 4 Year Prospective Cohort Study. BODEx, IRR, LAPAQ
744  2017 Core Components for a Clinically Integrated mHealth App for Asthma Symptom Monitoring. EHR
745  2017 Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project. PALS, SLE
746  2017 Development of a Smartphone Application to Monitor Pediatric Patient-Reported Outcomes. ---
747  2017 Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. AE, ePROs
748  2017 Do Patient Expectations Influence Patient-Reported Outcomes and Satisfaction in Total Hip Arthroplasty? A Prospective, Multicenter Study. fulfillment of expectations, HOOS, HSS, THA, UCLA
749  2017 Does Bony Regrowth Occur After Arthroscopic Femoroplasty in a Group of Young Adolescents? HOS-SSS, mHHS, NAHS, VAS
750  2017 Dual bronchodilation in COPD: lung function and patient-reported outcomes - a review. FDCs, LABA, LAMA
751  2017 Effect of employment status on length of hospital stay, 30-day readmission and patient reported outcomes after spine surgery. EBL, LOS
752  2017 Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis. DLQI, HRQoL, ISI, PASI, PtGA, SF-36
753  2017 Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study. HRQoL, NSCLC, OS, PFS
754  2017 Effects of immediate post-operative pain medication on length of hospital stay: does it make a difference? EBL, LOS, ODI, PCA, UTI
755  2017 Efficacy of Betahistine by Patient-Reported Outcomes and its Tolerability Profile in Indian Patients with Vestibular Vertigo. DHI, HADS, MCS, PCS, SADRs, SF-36v2
756  2017 eHealth System for Collecting and Utilizing Patient Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care) Among Cancer Patients: Mixed Methods Approach to Evaluate Feasibility and Acceptability. eHealth
757  2017 Electronic applications for the CFQ-R scoring. CF, CFQ-R
758  2017 Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients. aBC, CATREG, ePRO, HRQoL, MBC
759  2017 Evaluation of real-time use of electronic patient-reported outcome data by nurses with patients in home dialysis clinics. ePROs
760  2017 Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials. MS, PROMIS
761  2017 Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer. EOC
762  2017 Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease. OCCC, OS, PFI, PFS, ROC, TFI, TSST, TUDD
763  2017 Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer. AEs, ALK, NSCLC, ORR
764  2017 First 10-month results of the Vascular Quality Initiative Varicose Vein Registry. VCSS, VQI VVR
765  2017 Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities? BDI, CAT, COPD, Rs, SGRQ
766  2017 Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt. BMI, CASE, DAAs, HRQoL, LDSI-2.0, MSPSS
767  2017 Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. ECOG, EORTC, EQ-5D-3L, GHS, NSCLC, PD-L1, QLQ-C30, QLQ-LC13, QOL
768  2017 Healthcare Resource Utilization and Patient-Reported Outcomes Following Elective Surgery for Intradural Extramedullary Spinal Tumors. IDEM
769  2017 Higher Patient Expectations Predict Higher Patient-Reported Outcomes, But Not Satisfaction, in Total Knee Arthroplasty Patients: A Prospective Multicenter Study. HSS-KRES, HSS-KRFES, TKA
770  2017 HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment. ---
771  2017 How Comprehensive and Efficient Are Patient-Reported Outcomes for Rotator Cuff Tears? ADLs, JOA, QuickDASH, SF-36, UCLA
772  2017 Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives. PSA
773  2017 Impact of Age on Change in Self-Image 5 Years After Complex Spinal Fusion (≥5 Levels). ---
774  2017 Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis. EQ-5D, MRI, PHYS, PSYCH
775  2017 Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development. ---
776  2017 Impact of old age on patient-report outcomes and cost utility for anterior cervical discectomy and fusion surgery for degenerative spine disease. ACDF, QALYs
777  2017 Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study. ADA, HAQ, MCID, RA
778  2017 Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry. CDAI, RA, TNFi
779  2017 Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit. ESMO-MCBS, mRCC, OS, PFS, QOL, RCTs
780  2017 Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis. CDAI, mHAQ, RA, TCZ
781  2017 Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials. ADA, FACIT, HAQ-DI, MCS, MTX, PCS, PtGA, RA, SF-36, TCZ
782  2017 Impaired health-related quality of life in meningioma patients-a systematic review. HRQoL
783  2017 Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry. ePRO, ePROs
784  2017 Implementation and first results of a tablet-based assessment referring to patient-reported outcomes in an inpatient cancer care unit. HIS, QOL
785  2017 Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study. EHR, HF
786  2017 Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy. ---
787  2017 Implementing patient-reported outcome surveys as part of routine care: lessons from an academic radiation oncology department. ---
788  2017 Improving Cancer Care Through the Patient Experience: How to Use Patient-Reported Outcomes in Clinical Practice. ---
789  2017 Integration of Electronic Patient-Reported Outcomes Into Routine Cancer Care: An Analysis of Factors Affecting Data Completeness. ---
790  2017 Is Physician Quality Reporting System Worth the Cost to Report to Center for Medicare and Medicaid Services? CMS
791  2017 Is the use of minimally invasive fusion technologies associated with improved outcomes after elective interbody lumbar fusion? Analysis of a nationwide prospective patient-reported outcomes registry. MIS
792  2017 Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS). PCSS, QL
793  2017 Logistical challenges and design considerations for studies using acute anterior cruciate ligament injury as a potential model for early posttraumatic osteoarthritis. ACL, PTOA
794  2017 Loneliness predicts self-reported cold symptoms after a viral challenge. LON, RV39, SNI
795  2017 Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry. AE, All-TE, PGA, PY
796  2017 Lymphoma InterVEntion (LIVE) - patient-reported outcome feedback and a web-based self-management intervention for patients with lymphoma: study protocol for a randomised controlled trial. LIVE
797  2017 Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials. HAQ, JSN, RA, RAMRIS
798  2017 Magnetic Resonance Imaging Characterization and Clinical Outcomes After NeoCart Surgical Therapy as a Primary Reparative Treatment for Knee Cartilage Injuries. FDA, MRI, ROM
799  2017 Maintaining primacy of the patient perspective in the development of patient-centered patient reported outcomes. ---
800  2017 Mid-Term Results and Predictors of Patient-Reported Outcomes of Birmingham Hip Resurfacing. BHR, HOOS, UCLA
801  2017 Minimally invasive versus open fusion for Grade I degenerative lumbar spondylolisthesis: analysis of the Quality Outcomes Database. LOS, MIS, NRS, NRS-LP, ODI, QOD
802  2017 Minimum 2-Year Outcomes of Arthroscopic Management of Symptomatic Hip Labrum Tears in Patients With Global Acetabular Overcoverage. HA, HOS-ADL, HOS-SSS, mHHS
803  2017 Minimum Clinically Important Difference: Current Trends in the Spine Literature. MCID
804  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Commentary. ---
805  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 1: introduction. ---
806  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 2: terminology proposed to measure what matters in health. ---
807  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management. ---
808  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 4: patient-reported outcomes can inform clinical decision making in chronic care. PRO
809  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 5: patient-reported outcomes can be linked to epidemiologic measures to monitor populations and inform public health decisions. ---
810  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 6: creating national initiatives to support development and use-the PROMIS example. PRO
811  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 8: patient-reported outcomes in electronic health records can inform clinical and policy decisions. EHRs, PRO
812  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 9: anonymization and ethics considerations for capturing and sharing patient reported outcomes. ---
813  2017 Montreal Accord on Patient-Reported Outcomes (PROs) use series-Paper 7: modern perspectives of measurement validation emphasize justification of inferences based on patient reported outcome scores. PRO
814  2017 Need for Two-Year Patient-Reported Outcomes Score for Lumbar Spine Surgery Is Procedure-Specific: Analysis From a Prospective Longitudinal Spine Registry. MCID, ODI
815  2017 Neurologic Deficits Have a Negative Impact on Patient-Related Outcomes in Primary Presentation Adult Symptomatic Lumbar Scoliosis Surgical Treatment at One-Year Follow-up. DEF, NRS, ODI, PCS/MCS, SRS
816  2017 Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. EORTC, EQ-5D, QLQ-C30
817  2017 Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab. ADAs, CI, sPGA
818  2017 Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. alpha-Gal, ERT
819  2017 Outcomes and Disability After Massive Proximal Upper Extremity Reconstruction in a Resource-Limited Setting. DASH, JTT, MHQ, SF-36
820  2017 Outcomes of gluteus maximus and tensor fascia lata transfer for primary deficiency of the abductors of the hip. HOS-ADL, HOS-SSS, mHHS, NAHS, TFL, VAS
821  2017 Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue. BPI, FQ, HADS, IBD
822  2017 PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients. PALOMA-3, PFS
823  2017 Patient burden of Sjogren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity. QOL
824  2017 Patient Reported Outcome Assessment of Periodontal Therapy: A Systematic Review. NSPT, OHRQoL
825  2017 Patient reported outcome measures of quality of end-of-life care: A systematic review. EOL, LTC, PROMs
826  2017 Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions. ---
827  2017 Patient reported outcomes - experiences with implementation in a University Health Care setting. ---
828  2017 Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life. HRQoL, MM
829  2017 Patient Reported Outcomes Measurement Information System (PROMIS) in the upper extremity: the future of outcomes reporting? NIH, PROMIS
830  2017 Patient reported outcomes of autologous fat grafting after breast cancer surgery. AFG
831  2017 Patient-reported health status during pediatric cancer treatment. CNS, PROMIS, SD
832  2017 Patient-reported outcome scores underestimate the impact of major complications in patients undergoing spine surgery for degenerative conditions. CCMI, EQ-5D, ODI
833  2017 Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications. PRO, PRO-AEs, QOL
834  2017 Patient-reported outcomes (PROs) after total extraperitoneal hernia repair (TEP). COMI, QOL, TEP, TEP
835  2017 Patient-reported outcomes (PROs) in chronic urticaria. ---
836  2017 Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study. ---
837  2017 Patient-reported outcomes after lumbar epidural steroid injection for degenerative spine disease in depressed versus non-depressed patients. EQ-5D, LESIs, NRS-BP, NRS-LP, ODI, ZDS
838  2017 Patient-Reported Outcomes After Multiligament Knee Injury: MCL Repair Versus Reconstruction. IKDC, MCL, MLKI
839  2017 Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29. HR, MS, MSIS-29, MSIS-29-PHYS
840  2017 Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach. ERA, HAQ, SF-36, VAS
841  2017 Patient-reported outcomes following neoadjuvant chemotherapy or chemoradiotherapy treatment for esophageal cancer: a scoping review protocol. CRT, CT
842  2017 Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. EQ-5D, FACIT-F, HAQ-DI, MJS, MTX, PtGA, WPAI-RA
843  2017 Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. FACIT-F, HAQ-DI, MJS, PtGA, RA, VAS
844  2017 Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). bDMARDs, FACIT-F, HAQ-DI, MJS, PtGA, RA-BEACON, TNFis
845  2017 Patient-Reported Outcomes From the United States Clinical Trial for a Hybrid Cochlear Implant. CI, DUQ, SNHL, SSQ, UW-CAMP
846  2017 Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients. FACIT-F, HADS, IBD, SF-36, SIBDQ, WPAI
847  2017 Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis. ICC, PGA, RA, RAID, SF-12
848  2017 Patient-reported outcomes in cancer care - hearing the patient voice at greater volume. ePRO
849  2017 Patient-reported outcomes in cancer survivorship. ---
850  2017 Patient-reported outcomes in ductal carcinoma in situ: A systematic review. DCIS
851  2017 Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures. MS
852  2017 Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times. QOL
853  2017 Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy. MCID
854  2017 Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1. CKD
855  2017 Patient-reported Outcomes in Practice: Clinicians' Perspectives From an Inpatient Psychiatric Setting. ---
856  2017 Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study. DMT, RMS
857  2017 Patient-reported outcomes in Takayasu's arteritis. HRQoL, OMERACT, PRO, TAK
858  2017 Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. ANCOVA, DMARDs, EQ-5D, FACIT-F, HAQ-DI, MJS, MTX, PtGA, RA, SF-36, WPAI-RA
859  2017 Patient-reported outcomes of occipitocervical and atlantoaxial fusions in children. ASIA, HRQoL, NDI, ParentPedsQL, SRS-22
860  2017 Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues. CHC, DAA, QOL
861  2017 Patient-Reported Physical Function Measures in Cancer Clinical Trials. ---
862  2017 Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples. HTA, PRO
863  2017 Perceptions of Disease-Related Stress: A Key to Better Understanding Patient-Reported Outcomes Among Survivors of Congenital Heart Disease. CHD
864  2017 Persistent impairments 3years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. ---
865  2017 Physical Activity Minimum Threshold Predicting Improved Function in Adults With Lower-Extremity Symptoms. MV, RR
866  2017 Predicting falls among patients with multiple sclerosis: Comparison of patient-reported outcomes and performance-based measures of lower extremity functions. 2MW, ABC, AUCs, DTC, FES-I, MFIS, MS, OR, PBMs, T25FW, TUG
867  2017 Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial. HAQ-DI, MDA, QOL, TJC
868  2017 Preoperative Mental Health is not Predictive of Patient-reported Outcomes Following a Minimally Invasive Lumbar Discectomy. MCS, VAS
869  2017 Presentation approaches for enhancing interpretability of patient-reported outcomes (PROs) in meta-analysis: a protocol for a systematic survey of Cochrane reviews. PROMs
870  2017 Prevalence of Neuropathic Pain and Patient-Reported Outcomes in Korean Adults with Chronic Low Back Pain Resulting from Neuropathic Low Back Pain. CLBP, NP, QOL, VAS
871  2017 Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. FACT-HN, HNC, OM, OMAS, OMWQ-HN, QOL
872  2017 Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. AI, HAQ, VAS
873  2017 Prospective Clinical and Radiographic Outcomes After Concomitant Anterior Cruciate Ligament Reconstruction and Meniscal Allograft Transplantation at a Mean 5-Year Follow-up. KL
874  2017 Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol. NMIBC, SI
875  2017 Psychosocial Patient-Reported Outcomes in Pediatric and Adolescent Diabetes: a Review and Case Example. ---
876  2017 Publication of comparative effectiveness research has not increased in high-impact medical journals, 2004-2013. CER
877  2017 Racial and ethnic variations in one-year clinical and patient-reported outcomes following breast reconstruction. ---
878  2017 Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients. API
879  2017 Rehabilitation and Improvement of Health-Related Quality-of-Life Detriments in Individuals With Chronic Ankle Instability: A Meta-Analysis. CAI, CIs, ESs, HRQL, PEDro
880  2017 Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis. HAQ, RA
881  2017 Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial. EORTC, HRQoL
882  2017 Research Pearls: The Significance of Statistics and Perils of Pooling. Part 1: Clinical Versus Statistical Significance. ---
883  2017 Responsiveness and Internal Validity of Common Patient-Reported Outcome Measures Following Total Shoulder Arthroplasty. ASES, ROC, SANE, TSA, WOOS
884  2017 Responsiveness to Change of Functional Limitation Reporting: Cross-sectional Study Using the Intermountain ROMS Scale in Outpatient Rehabilitation. CMS, MCID, ROMS
885  2017 Revisions for screw malposition and clinical outcomes after robot-guided lumbar fusion for spondylolisthesis. MI-PLIF, ODI, VAS
886  2017 Routine inclusion of long-term functional and patient-reported outcomes into trauma registries: The FORTE project. CI, HRQoL, SF-12
887  2017 Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors. csDMARDs, HAQ-DI, MCID, PtGA, RA, RAID, SF-36, TNF-IR, WPS-RA, WPS-RA
888  2017 Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1). i.v, PsA
889  2017 Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes. BMI, MDHAQ, MOS, ORAR, RA, RAID, VAS
890  2017 Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis. HCV
891  2017 Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. DKA, HbA1c
892  2017 Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes. CIs
893  2017 Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects. SEM
894  2017 Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity. HCV, IFN
895  2017 Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care. GI, LLTEs, SCP
896  2017 Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes. OML, SSc
897  2017 The challenge of measuring intra-individual change in fatigue during cancer treatment. CAT
898  2017 The Chorus of User Voices: Meeting the Challenge of Patient-Reported Outcomes From Medications. ---
899  2017 The Emerging Role of Patient-Reported Outcomes (PROs) in Clinical Trials: An Indian Perspective. PRO
900  2017 The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature. ED, HRQoL, SCLC
901  2017 The impact of antiviral therapy for hepatitis C on the quality of life: a perspective. DAAs, HRQoL
902  2017 The Impact of Participation in Online Cancer Communities on Patient Reported Outcomes: Systematic Review. ---
903  2017 The impact of symptomatic knee osteoarthritis on overall gait pattern deviations and its association with performance-based measures and patient-reported outcomes. GDI, OA, PBMs, SLMS, TUG
904  2017 The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature. QOL, STS
905  2017 The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies. IA-NS, MCID, MD, OA, VAS, WOMAC
906  2017 The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer. DSS, HR, OS, PSSCAN, QOL
907  2017 Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial. DMARDs, FACIT-F, HAQ DI, MOS-Sleep, PtGA, RA, SF-36
908  2017 Towards a privacy preserving cohort discovery framework for clinical research networks. CRNs, ECC, EHRs, HCUP, HIPAA, NIS, PPCD
909  2017 Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes. BSS, OIC, PAC-QOL, PAC-SYM, SBMs
910  2017 Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms. BPH, BPH QoL K1, EQ-5D, IPSS, OAB
911  2017 Use of patient-reported outcomes and satisfaction for quality assessments. OR
912  2017 Using Quality Improvement Principles to Enhance Long-Term Completion of Patient-Reported Outcomes after Ventral Hernia Repair. AHSQC, QI, VHR
913  2017 Utilization of Patient-Reported Outcomes to Guide Symptom Management during Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer. EPIC-CP, SBRT
914  2017 Variability in Outcome Reporting for Operatively Managed Anterior Glenohumeral Instability: A Systematic Review. ROM
915  2017 Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy. CML, HRQoL, MCS, PCS, TKIs
916  2017 Visualizing the Patient-Reported Outcomes Measurement Information System (PROMIS) Measures for Clinicians and Patients. EHR, PROMIS
917  2017 Vitamin E diffused highly cross-linked polyethylene in total hip arthroplasty at five years: a randomised controlled trial using radiostereometric analysis. RCT, THA
918  2017 Wake up to sleep: The effects of lacosamide on daytime sleepiness in adults with epilepsy. ESS, LCM, MSL, MWT
919  2017 What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability. CI, OR
920  2017 What makes a tool appropriate to assess patient-reported outcomes of periodontal disease? ---
921  2017 What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions. CE, QOL
922  2017 When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time. GRC, MCS, MS, QOL
923  2017 [Outcome Quality in Medical Rehabilitation: Relationship Between "Patient-Reported Outcomes" (PROs) and Social Security Contributions]. RSD
924  2018 "Loneliness predicts self-reported cold symptoms after a viral challenge": Correction to LeRoy et al. (2017). LON, RV39, SNI
925  2018 A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. DAA, HCV
926  2018 A cross-sectional study of vitamin D levels in a large cohort of patients with rheumatic diseases. ---
927  2018 A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy. ---
928  2018 A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. AIMSS, ELPh, ZAP
929  2018 A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer. HRQoL
930  2018 A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. OAB, PERSPECTIVE
931  2018 A qualitative study examining the benefits and challenges of incorporating patient-reported outcome substance use and mental health questionnaires into clinical practice to improve outcomes on the HIV care continuum. MH, SU
932  2018 A qualitative study of patients' perceptions of the utility of patient-reported outcome measures of symptoms in primary care clinics. PROMIS, SPADE pentad
933  2018 A retrospective review comparing two-year patient-reported outcomes, costs, and healthcare resource utilization for TLIF vs. PLF for single-level degenerative spondylolisthesis. ---
934  2018 A Systematic Method for Exploring Data Attributes in Preparation for Designing Tailored Infographics of Patient Reported Outcomes. ---
935  2018 A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy. HRQoL, RCTs
936  2018 A systematic review of the quality of reporting of simulation studies about methods for the analysis of complex longitudinal patient-reported outcomes data. ---
937  2018 Acetabular microfracture in hip arthroscopy: clinical outcomes with minimum 5-year follow-up. HOS-SSS, mHHS, NAHS, THA, VAS
938  2018 Aesthetic Treatment Positively Impacts Social Perception: Analysis of Subjects From the HARMONY Study. OROs
939  2018 Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung. AEs, OS, OTP, PFS, QOL, SCC
940  2018 Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy. AEs
941  2018 AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported Outcomes. ---
942  2018 American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Patient-Reported Outcomes in an Enhanced Recovery Pathway. ERPs, POQI, PROMs
943  2018 An app for patient education and self-audit within an enhanced recovery program for bowel surgery: a pilot study assessing validity and usability. ERPs, ICC, SUS
944  2018 An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin. IWQOL-Lite
945  2018 Application and Benefits of Web-Mediated Symptom Reporting for Patients Undergoing Immunotherapy: A Clinical Example. ---
946  2018 Are patient-reported outcomes of physical function a valid substitute for objective measurements? pro-pf
947  2018 Arthroscopic Capsular Plication in Patients With Labral Tears and Borderline Dysplasia of the Hip: Analysis of Risk Factors for Failure. LCEA, mHHS, NAHS, VAS
948  2018 Arthroscopic Treatment of Iliopsoas Snapping in Patients With Radiographic Acetabular Dysplasia Using Iliopsoas Fractional Lengthening and Capsular Plication. LCEA
949  2018 Assessing Health-Related Quality of Life in Patients With Diabetic Foot Disease: Why Is It Important and How Can We Improve? The 2017 Roger E. Pecoraro Award Lecture. FAAM, HRQoL
950  2018 Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review. NMIBC, PROMs
951  2018 Assessment of patient-reported outcomes after polytrauma: protocol for a systematic review. ---
952  2018 Association between limb alignment and patient-reported outcomes after total knee arthroplasty using an implant that reproduces anatomical geometry. FTA, HKAA, J-KOOS, J-KOOS-A, KA, KSS, TKA
953  2018 Association between periodontal health status and patient-reported outcomes in patients managed in a non-specialist, general dental practice. ABL, BOP, PPD
954  2018 Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus. LupusPRO, SLE
955  2018 Associations of Race and Ethnicity With Patient-Reported Outcomes and Health Care Utilization Among Older Adults Initiating a New Episode of Care for Back Pain. BOLD, BP, CI, RVUs
956  2018 Associations of Vitamin D Levels and Vitamin D Receptor Genotypes with Patient-Reported Outcome/Disease Activity in Patients with Rheumatoid Arthritis. RA, VDR
957  2018 At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes. ---
958  2018 Barriers and Benefits to the Use of Patient-Reported Outcome Measures in Routine Clinical Care: A Qualitative Study. ---
959  2018 Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity. AUC, CD, CDAI, FC, Hct, hs-CRP, SES-CD
960  2018 Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries. BMs, BTAs, QOL, SREs
961  2018 BREAST-Q Measurement of the Patient Perspective in Oncoplastic Breast Surgery: A Systematic Review. HRQoL
962  2018 Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis. RA
963  2018 Can Early Patient-reported Outcomes Be Used to Identify Patients at Risk for Poor 1-Year Health Outcomes After Lumbar Laminectomy With Arthrodesis? MID, OR
964  2018 Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry. HRQoL
965  2018 Clinical Outcomes After Microfracture of the Knee: Midterm Follow-up. BMI, IKDC, KOOS, SF-12, WOMAC
966  2018 Clinical Outcomes of Meniscal Allograft Transplantation With or Without Other Procedures: A Systematic Review and Meta-analysis. MAT
967  2018 Clinical outcomes research in spine surgery: what are appropriate follow-up times? CSORN, DS, MCS, PCS, VAS
968  2018 Collecting Patient Reported Outcomes in the Wild: Opportunities and Challenges. ---
969  2018 Comparing and transforming PROMIS utility values to the EQ-5D. QALY
970  2018 Comparison of Postoperative Outcomes between Primary MIS TLIF and MIS TLIF as a Revision Procedure to Primary Decompression. LD
971  2018 Comparison of Surgeon Performance of Rotator Cuff Repair: Risk Adjustment Toward a More Accurate Performance Measure. ASES, VR-12
972  2018 COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans. COMPASS, CP
973  2018 Correlation of 2-year SRS-22r and ODI patient-reported outcomes with 5-year patient-reported outcomes after complex spinal fusion: a 5-year single-institution study of 118 patients. ODI, SRS
974  2018 Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease. COPD, SGRQ, TDI
975  2018 Data Management for Applications of Patient Reported Outcomes. EHR, HCSRN, HRA
976  2018 Decision to Return to Sport Participation After Anterior Cruciate Ligament Reconstruction, Part II: Self-Reported and Functional Performance Outcomes. ACL, RTS
977  2018 Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis: insights from the Quality Outcomes Database. MCID, MDC, NRS, ODI
978  2018 Demographics and Clinical Outcomes of Patients Undergoing Anterior Cruciate Ligament Reconstruction with a Planned or Unplanned Hybrid Graft. ACLR
979  2018 Descriptive Epidemiology of the MOON Shoulder Instability Cohort. ASES, MRI, ROM, SANE, WOSI
980  2018 Determining Success or Failure After Foot and Ankle Surgery Using Patient Acceptable Symptom State (PASS) and Patient Reported Outcome Information System (PROMIS). ANOVA, PASS, PF, PI, PROMIS, ROC
981  2018 Development of the KOOSglobal Platform to Measure Patient-Reported Outcomes After Anterior Cruciate Ligament Reconstruction. ACL, IKDC, KOOS, KOOS, JR
982  2018 Digital Follow-Up and the Perspective of Patient-Centered Care in Oncology: What's the PROblem? ---
983  2018 Disablement Model and Health-Related Quality of Life Classification for Patient-Reported Outcomes Measurement Information System (PROMIS) Instruments. HRQoL, PROMIS
984  2018 Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjogren's syndrome. pSS
985  2018 Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials. CDSD, CeD PRO, FDA
986  2018 Do Former Smokers Exhibit a Distinct Profile Before and After Lumbar Spine Surgery? ODI
987  2018 Does Iliopsoas Lengthening Adversely Affect Clinical Outcomes After Hip Arthroscopy? A Multicenter Comparative Study. FAI, IFL, MCID, PASS, THA
988  2018 Does routinely collected patient-reported outcome data represent the actual case-mix of elective coronary revascularization patients? CABG, HRQoL, PCI
989  2018 Does surgeon experience affect patient-reported outcomes 1 year after primary total hip arthroplasty? SHAR, THA, VAS
990  2018 Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings. BM, HRQoL, NSCLC, RALS
991  2018 Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes. FACIT, HAQ-DI, MTX, RA
992  2018 Effect of pre-injection opioid use on post-injection patient-reported outcomes following epidural steroid injections for radicular pain. CI, EQ-5D, ESIs, MCID, MEA, ODI/NDI, OR
993  2018 Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study. ARR, DMF, GA, RMS
994  2018 Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study. CIndU, CSU
995  2018 Effects of etanercept on the patient-perceived results (PROs) in patients with moderate-to-severe plaque psoriasis: systematic review of the literature and meta-analysis. ETN, RCT
996  2018 Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. CRF, HIIT, HRQoL, TCS, UC
997  2018 Effects of Treatment of Chronic Hepatitis B Virus Infection onPatient-Reported Outcomes. HBV
998  2018 Efficacy and Safety of Nebulized Glycopyrrolate/eFlow Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors. COPD, CV, GLY, GOLDEN, TEAEs, TIO
999  2018 Electronic Collection of Multilingual Patient-Reported Outcomes across Europe. ePRO
1000  2018 Endoscopic Repair of Partial-Thickness Undersurface Tears of the Abductor Tendon: Clinical Outcomes With Minimum 2-Year Follow-up. VAS
1001  2018 Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol. OS
1002  2018 Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases. CD, GI, GI-PROMIS, IBD, PROMIS, QOL, UC
1003  2018 Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. aHUS, ECU, EMPRO, FACIT-F, HIT-6, HRQoL, HUS, QOL, VAS
1004  2018 Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. NCRI
1005  2018 Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study. CDAI, csDMARD, M/HDA, RA, TNFi
1006  2018 Experiences of Inpatient Bone Marrow Transplantation Nurses and Providers Using Electronic Symptom Reporting. ---
1007  2018 Exploring levels and correlates of health literacy in Arabic and Vietnamese immigrant patients with cancer and their English-speaking counterparts in Australia: a cross-sectional study protocol. ---
1008  2018 Exploring patient-reported outcomes following percutaneous coronary intervention: A qualitative study. FDA, PCI, PROMs
1009  2018 Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature. ISOQOL, PRISMA, SLR
1010  2018 Factors affecting patient-reported outcomes after red blood cell transfusion in medical patients. HRQoL, RBC
1011  2018 Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months. DMARDs, EQ-5D, HRQoL, KHAQ, RA
1012  2018 Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium. EDSS, NYSMSC, PwMS
1013  2018 Feasibility of Collecting Patient-Reported Outcomes for Inpatient Rehabilitation Quality Reporting. ---
1014  2018 French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes. HCV, LDV, SVR-12
1015  2018 From the Child's Word to Clinical Intervention: Novel, New, and Innovative Approaches to Symptoms in Pediatric Palliative Care. HRQoL
1016  2018 Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review. COPD, HRQoL
1017  2018 Getting Better or Getting Well? The Patient Acceptable Symptom State (PASS) Better Predicts Patient's Satisfaction than the Decrease of Pain, in Knee Osteoarthritis Subjects Treated with Viscosupplementation. OA, PASS, PGAP, WOMAC
1018  2018 Heading and unintentional head impacts have opposing associations with Patient Reported Outcomes in amateur soccer players. ---
1019  2018 Health Outcomes Reported by Dental Patients. dPRO, dPROMs, PROMs
1020  2018 Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2. AUC-pain, HRQoL
1021  2018 Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. HCV, IFN, RBV, SOF, SVRs
1022  2018 Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens. HCV, OST, SVR-12
1023  2018 Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antivirals. CSS, DAAs, ESS, HCV, PSQI, QOL, RLS
1024  2018 High Rate of Return to Cycling After Hip Arthroscopy for Femoroacetabular Impingement Syndrome. FAIS, HOS-ADL, mHHS
1025  2018 High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study. QOL, RRMS
1026  2018 Higher Improvement in Patient-Reported Outcomes Can Be Achieved After Transforaminal Lumbar Interbody Fusion for Clinical and Radiographic Degenerative Spondylolisthesis Classification Type D Degenerative Lumbar Spondylolisthesis. CARDS
1027  2018 Hip Arthroscopic Surgery With Labral Preservation and Capsular Plication in Patients With Borderline Hip Dysplasia: Minimum 5-Year Patient-Reported Outcomes. HOS-SSS, LCEA, mHHS, NAHS, VAS
1028  2018 Hip arthroscopy following contralateral total hip arthroplasty: a multicenter matched-pair study. LCEA, THA
1029  2018 Home Health Services Are Not Required for Select Total Hip Arthroplasty Candidates: Assessment and Supplementation With an Electronic Recovery Application. EPRAs, HHS, THA, VR-12
1030  2018 How Long Does It Take for Patients to Complete PROMIS Scores?: An Assessment of PROMIS CAT Questionnaires Administered at an Ambulatory Sports Medicine Clinic. CAT, PF, PI, PROMIS, TTC, UE
1031  2018 How Returning Aggregate Research Results Impacts Interest in Research Engagement and Planned Actions Relevant to Health Care Decision Making: Cohort Study. AOR, ARRs, PCA
1032  2018 How should we assess patient-reported outcomes in the onco-hematology clinic? ---
1033  2018 Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study. AAP, BPI-SF, ENZ, mCRPC
1034  2018 Impact of Joint Involvement on Patients Reported Outcomes in Systemic Lupus Erythematosus. GH, HAQ, SLE, VAS
1035  2018 Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial. DEPO, ODI, VAS
1036  2018 Impact of question order on prioritisation of outcomes in the development of a core outcome set: a randomised controlled trial. CI, COS
1037  2018 Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease. ES, MCID, RA, TNFi
1038  2018 Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis. csDMARDs, MCID, RA, RCTs, TCZ
1039  2018 Implementation of an electronic routine outcome monitoring at an inpatient unit for psychosomatic medicine. eROM
1040  2018 Implementation of Patient-Reported Outcomes in Routine Medical Care. ---
1041  2018 Implementation of Patient-Reported Outcomes Measurement Information System Data Collection in a Private Orthopedic Surgery Practice. CATs, CI
1042  2018 Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians. ---
1043  2018 Improved Assessment of Bolus Clearance in Patients With Achalasia Using High-Resolution Impedance Manometry. EII
1044  2018 Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study. DMSRQ, Gla-300, HbA1c
1045  2018 Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial. CRP, EE, FACIT-F, HAQ-DI, MCIDs, PsA, SF-36, TNFi
1046  2018 Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. NASH, SEL
1047  2018 Influence of racial disparities on patient-reported satisfaction and short- and long-term perception of health status after elective lumbar spine surgery. AA, ODI, VAS-BP, VAS-LP
1048  2018 Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes. AE, CRT, IMPT, VMAT
1049  2018 Interpreting Patient-Reported Outcome Results: Is One Minimum Clinically Important Difference Really Enough? MCID, PRWE
1050  2018 Intersurgeon Cost Variability in Anterior Cervical Discectomy and Fusion. ACDF
1051  2018 Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study. BSA, DLQI, GenPs, GenPs-SFQ, GPSIS, GPSS
1052  2018 LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life. COPD, FDCs, HRQoL, HS, LABAs, LAMAs, RCTs
1053  2018 Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use. NAFLD, NASH
1054  2018 Leveraging Patient-Reported Outcomes Using Data Visualization. ---
1055  2018 Life after endometrial cancer: A systematic review of patient-reported outcomes. BMI, EC, QOL
1056  2018 Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation. AE, EMRs
1057  2018 Maintenance of Remission with Etanercept-DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis. ETN, LDA, PBO, RA
1058  2018 Measurement of patient-reported outcomes. 2: Are current measures failing us? PROM
1059  2018 Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View. ---
1060  2018 Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study. anti-TNF, MDA, PsA, QOL, VLDA
1061  2018 Minimum Clinically Important Difference in SF-36 Scores for Use in Degenerative Cervical Myelopathy. DCM, MCID, MCS, NDI, PCS, ROC, SEM
1062  2018 Mining telemonitored physiological data and patient-reported outcomes of congestive heart failure patients. CHF
1063  2018 Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. FACITv4, HAQ, HRQoL, RA, SF-36v2, SLE
1064  2018 Musculoskeletal-based Patient-reported Outcome Performance Measures, Where Have We Been-Where Are We Going. ---
1065  2018 No Difference in the KOOS Quality of Life Subscore Between Anatomic Double-Bundle and Anatomic Single-Bundle Anterior Cruciate Ligament Reconstruction of the Knee: A Prospective Randomized Controlled Trial With 2 Years' Follow-up. ACL, KOOS, QOL
1066  2018 Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes. BMT, HCT, IT
1067  2018 Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. BGDs, CBCS, CBCS-HCV, HCV
1068  2018 Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease. IBD, IL
1069  2018 Obese Patients Benefit, but do not Fare as Well as Nonobese Patients, Following Lumbar Spondylolisthesis Surgery: An Analysis of the Quality Outcomes Database. DLS, EQ-5D, NRS, ODI
1070  2018 Oh, the Places We'll Go: Patient-Reported Outcomes and Electronic Health Records. EHRs
1071  2018 Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer. UCLA-PCI
1072  2018 Outcome measurement in plastic surgery. PROMs
1073  2018 Outcomes of Hip Arthroscopy in Adolescents: A Comparison of Acute Versus Chronic Presentation. Two-Year Minimum Follow-up. HOS-SSS, mHHS, NAHS, VAS
1074  2018 Outcomes of Joint Preservation Procedures for Cartilage Injuries in the Hip: A Systematic Review and Meta-analysis. ---
1075  2018 Outcomes of reverse shoulder arthroplasty in small- and large-stature patients. ROM, RSA
1076  2018 Pain after orthopaedic surgery: differences in patient reported outcomes in the United States vs internationally. An observational study from the PAIN OUT dataset. CI, TKR, US
1077  2018 Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients. CRP, GS, PD, RA, US, VAS
1078  2018 Pain, impaired functioning, poor satisfaction and diminished health status eight years following perilunate (fracture) dislocations. ---
1079  2018 Patient Adoption and Utilization of a Web-Based and Mobile-Based Portal for Collecting Outcomes After Elective Orthopedic Surgery. ---
1080  2018 Patient Engagement in ACO Practices and Patient-reported Outcomes Among Adults With Co-occurring Chronic Disease and Mental Health Conditions. ACOs
1081  2018 Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer. CDF, PNQ
1082  2018 Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication. ---
1083  2018 Patient-reported outcomes (PROs) argue against the limited use of peritoneal dialysis inend-stage renal disease
1084  2018 Patient-reported outcomes (PROs) versus patient-reported outcome measures (PROMs)-Is there a difference? PROMs
1085  2018 Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery. BPI, MDASI, SINS
1086  2018 Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis. ---
1087  2018 Patient-Reported Outcomes and Costs Associated With Revision Surgery for Degenerative Cervical Spine Diseases. EQ-5D, mJOA, NDI, NRS-AP, NRS-NP
1088  2018 Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients. ---
1089  2018 Patient-reported outcomes associated with different restorative techniques in pediatric dentistry: A systematic review and MTC meta-analysis. DIC, MTC, OHRQoL
1090  2018 Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States. PV, QOL, WPAI-SHP
1091  2018 Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. ADT, BFI, BPI-SF, ECOG, FACT-P, HR, HRQoL
1092  2018 Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir. HCV, SVR12
1093  2018 Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices. AS, BT, EBRT, LPC, QLQ-C30, RP
1094  2018 Patient-Reported Outcomes for Breast Cancer. ---
1095  2018 Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia. CI, InO, QOL, SOC
1096  2018 Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias. DT, FCT, GI
1097  2018 Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. FACIT-F, HAQ-DI, LSM, MCID, MCS, PCS, PtGA, RA, RAID, VASs
1098  2018 Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients. EOT, HRQoL, OAB, PPBC, TS-VAS
1099  2018 Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer. ALK, CNS, GHS, HRQoL
1100  2018 Patient-reported outcomes in adults with congenital heart disease: Inter-country variation, standard of living and healthcare system factors. ConHD
1101  2018 Patient-reported outcomes in asthma clinical trials. ---
1102  2018 Patient-reported outcomes in cirrhosis: A scoping review of the literature. ---
1103  2018 Patient-reported outcomes in daily clinical practise in HIV outpatient care. ---
1104  2018 Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. BAs, HRQoL, SpA
1105  2018 Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir. CES-D, CI, EQ-5D, MDD, VAS
1106  2018 Patient-Reported Outcomes in Foot and Ankle Surgery. ---
1107  2018 Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir. EBR/GZR, FACIT-Fatigue, H2H, HCV, SF-36v2, SOF/PR
1108  2018 Patient-reported outcomes in moderate-to-severe allergic asthmatics treated with omalizumab: a systematic literature review of randomized controlled trials. HRQoL, RCTs
1109  2018 Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer. CI, HR, HRQoL, NSCLC, OS, PD-L1, TTD
1110  2018 Patient-Reported Outcomes in Older Adults With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure Therapy. CPAP, ESS, FOSQ, FSS, OSA, PHQ-9
1111  2018 Patient-reported outcomes in ovarian cancer: are they key factors for decision making? QAPFS, TOI, TWiST
1112  2018 Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER). EOT, ER, HRQoL, MID, OAB, OAB-S, PPBC
1113  2018 Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice. DMT, EDSS, EDSS, MS, MusiQoL, SDMT
1114  2018 Patient-reported outcomes in trauma: a scoping study of published research. ---
1115  2018 Patient-Reported Outcomes of Capsular Repair Versus Capsulotomy in Patients Undergoing Hip Arthroscopy: Minimum 5-Year Follow-up-A Matched Comparison Study. MCID, mHHS, PASS
1116  2018 Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANORAMA-1 trial. BTZ, DEX, PAN, PBO, QOL
1117  2018 Patient-reported outcomes with nivolumab in advanced solid cancers. HRQoL, RCC, SCCHN
1118  2018 Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. ---
1119  2018 Patients With Valgus Alignment and Patients With Varus Alignment Are Not Mere Opposites of Each Other Prior to Total Knee Arthroplasty. ---
1120  2018 Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases. ILD, QOL
1121  2018 Patterns and trends in insulin initiation and intensification among patients with type 2 diabetes mellitus in the Western Pacific region. QOL, T2DM, VISION, WP
1122  2018 Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research. CLBP, EQ-5D, EQ-VAS, NLBP, nTT, QBPDS, QOL, TT
1123  2018 Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). FACT, FACT-G PWB, MY-Health, PF, PROMIS
1124  2018 Physiotherapy Questionnaires App to Deliver Main Musculoskeletal Assessment Questionnaires: Development and Validation Study. AOFAS, FAOS
1125  2018 Postoperative Cervical Sagittal Realignment Improves Patient-Reported Outcomes in Chronic Atlantoaxial Anterior Dislocation. AAD, JOA, NDI, SF-12 PCS
1126  2018 Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. BMI, CDAI, DAS28, HAQ, RA, SDAI
1127  2018 Press Ganey Outpatient Medical Practice Survey Scores Do Not Correlate With Patient-Reported Outcomes After Primary Joint Arthroplasty. ---
1128  2018 Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer. BPI, FSFI, QOL, SABIS-G
1129  2018 Prospective multicentre cohort study of patient-reported outcomes and complications following major abdominal neoplastic surgery (PATRONUS) - study protocol for a CHIR-Net student-initiated German medical audit study (CHIR-Net SIGMA study). CHIR-Net, EORTC, HRQoL, PATRONUS, UTN
1130  2018 Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary data. PWH, RWD
1131  2018 Protocol for a randomized trial of the effect of timing of cholecystectomy during initial admission for predicted mild gallstone pancreatitis at a safety-net hospital. IOC, LOS
1132  2018 Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire. EQ-5D-5L, PROBE
1133  2018 Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review. PBT, PRISMA, QOL
1134  2018 Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial. FOSI, gBRCA, QOL
1135  2018 Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. CI, QLQ-C30, TTD
1136  2018 Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial. CI, PCT
1138  2018 Randomized Controlled Trials in Adult Traumatic Brain Injury: A Systematic Review on the Use and Reporting of Clinical Outcome Assessments. CDEs, COAs, CONSORT, GOS/GOSE, RCTs, TBI
1139  2018 RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. RCAT, RQLQ, RTSS
1140  2018 Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials. LDA, MJS, RA, VAS
1141  2018 Relationship between patient-reported outcomes and clinical outcomes in metastatic castration-resistant prostate cancer: post hoc analysis of COU-AA-301 and COU-AA-302. ECOG PS, FWB, mCRPC, OS, PWB, rPFS
1142  2018 Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). ICC, MCID
1143  2018 Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement. MDA
1144  2018 Return to Play After Hip Arthroscopy: A Systematic Review and Meta-analysis. mHHS, RTP
1145  2018 Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis. MCID, ODI, VAS
1146  2018 Rod fracture in adult spinal deformity surgery fused to the sacrum: prevalence, risk factors, and impact on health-related quality of life in 526 patients. ASD, CC, HR, ODI, RF, SRS-30, SS
1147  2018 Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study. DLQI, NAPSI, PASI, VAS
1148  2018 Sarilumab: patient-reported outcomes in rheumatoid arthritis. RA
1149  2018 Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study. HDA, HRQoL, LDA, PASDAS, PsA, TNFi
1150  2018 Selection, implementation, and interpretation of patient-centered shoulder and elbow outcomes. ---
1151  2018 Serious Adverse Events Significantly Reduce Patient-Reported Outcomes at 2-Year Follow-up: Nonoperative, Multicenter, Prospective NIH Study of 105 Patients. ASLS, MCID, MCS/PCS, NIAMS, ODI, SAEs, SF-12, SRS-22
1152  2018 Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial. MTX, MTX-IR, PGA, RA
1153  2018 Single ray amputation in traumatic injury of the hand: review of literature. ---
1154  2018 Sociodemographic, Clinical and Patient-Reported Outcomes and Readmission After Heart Valve Surgery. DenHeart, EQ-5D, PCI, ROC, SF-12
1155  2018 Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naive chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3. SOF/VEL, SVR12, VOX
1156  2018 Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. RCTs
1157  2018 Structural validity of the Dutch version of the disability of arm, shoulder and hand questionnaire (DASH-DLV) in adult patients with hand and wrist injuries. DASH
1158  2018 Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy. GHS, OS, PFS, QOL, SCC, TTD
1159  2018 Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next. ---
1160  2018 Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. PICOS-T, SUA
1161  2018 Systemwide Implementation of Patient-Reported Outcomes in Routine Clinical Care at a Children's Hospital. ---
1162  2018 Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. HEP, MS, PT, TR
1163  2018 Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. CDAI, CRP, DAPSA, DMARD, ESR, PsA
1164  2018 The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS). GenPs, GPSS, NRS
1165  2018 The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health. GenPs, GenPs-SFQ, GenPs-SFQ, HRQoL
1166  2018 The effect of lower socioeconomic status insurance on outcomes after primary shoulder arthroplasty. VAS
1167  2018 The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). EQUAL, PROMIS, TUG
1168  2018 The HOPE Pilot Study: Harnessing Patient-Reported Outcomes and Biometric Data to Enhance Cancer Care. HOPE, SD
1169  2018 The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study. BMI, DAAs, EOT, HCV, HGS, HRQL, MCS
1170  2018 The impact of remission status on patients' experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data. AML
1171  2018 The importance of patient-reported outcomes in clinical trials and strategies for future optimization. ---
1172  2018 The Influence of Full-Thickness Chondral Defects on Outcomes Following Meniscal Allograft Transplantation: A Comparative Study. FTD, MAT
1173  2018 The lack of standardized outcome measures following lower extremity injury in elite soccer: a systematic review. ---
1174  2018 The Mark Coventry Award: Patellofemoral Arthroplasty Results in Better Range of Movement and Early Patient-reported Outcomes Than TKA. AUC, KOOS, OKS, PFA
1175  2018 The Predictive Value of Preoperative Health-Related Quality-of-Life Scores on Postoperative Patient-Reported Outcome Scores in Lumbar Spine Surgery. HRQoL, ODI, SF-36v2
1176  2018 The Role of Wearable Devices in Multiple Sclerosis. MS, MWD, PwMS
1177  2018 Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review. DM2, NMDs
1178  2018 Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C. CLDQ, DCV, FACIT-F, HCV, RBV, SF-36, SMV, SOF
1179  2018 Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). ANZCTR, QOL
1180  2018 Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? DIF, HD
1181  2018 Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. DTSQ, SGLT2
1182  2018 Use of Patient-Related Outcomes After Orthopaedic Trauma: Helpful or Not So Much? ---
1183  2018 Use of Patient-Reported Outcome Measures in Quality Oncology Practice Initiative-Registered Practices: Results of a National Survey. EHRs
1184  2018 Using generalized estimating equations and extensions in randomized trials with missing longitudinal patient reported outcome data. GEEs
1185  2018 Validating the Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive tests for upper extremity fracture care. CAT, PROMIS, PROMIS PF, PROMIS UE
1186  2018 Validity and comprehensibility of outcome measures in children with shoulder and elbow disorders: creation of a new Pediatric and Adolescent Shoulder and Elbow Survey (Pedi-ASES). ASES, Pedi-ASES, QuickDASH
1187  2018 Variability in the utility of predictive models in predicting patient-reported outcomes following spine surgery for degenerative conditions: a systematic review. ---
1188  2018 Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. HRQoL, SLE
1189  2018 Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients. HR, OR, PS
1190  2018 [Empirical Assessment of Patient-Reported Outcomes and Exemplary Introduction to Health-Related Quality of Life]. HRQoL
1191  2018 [Evolving Therapeutic Strategies in the Inflammatory Bowel Disease]. ---
1192  2019 "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. RA
1193  2019 A beta-binomial mixed-effects model approach for analysing longitudinal discrete and bounded outcomes. ---
1194  2019 A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis. EQ-5D, MIS, MIS TLIF, NASS, NRS, ODI, QOD, TLIF
1195  2019 A Machine Learning Approach to Classifying Self-Reported Health Status in a cohort of Patients with Heart Disease using Activity Tracker Data. AUC, HMM, PROMIS, SIHD
1196  2019 A narrative review of data collection and analysis guidelines for comparative effectiveness research in chronic pain using patient-reported outcomes and electronic health records. CER, EHRs
1197  2019 A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease. CD, IBD, PROBE, PROBE, QOL, UC
1198  2019 A PRO-cision Medicine Methods Toolkit to Address the Challenges of Personalizing Cancer Care Using Patient-Reported Outcomes: Introduction to the Supplement. ---
1199  2019 A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms. ASA, HA, KOOS, OA, SANE, VAS
1200  2019 A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. FSMPG, Gla-300
1201  2019 A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. BMs, BTAs, QOL, SREs
1202  2019 A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016). EMA, FDA
1203  2019 A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis. CROs, RT
1204  2019 A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice. CDS
1205  2019 A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants. CT, DOAC, HRQoL, OS
1206  2019 A Systematic Review of Patient-Reported Outcomes for Cosmetic Indications of Botulinum Toxin Treatment. BTX, QOL
1207  2019 Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology. IT, TEP
1208  2019 Adverse Childhood Experiences Are Not Associated With Patient-reported Outcome Measures in Patients With Musculoskeletal Illness. ACEs, CI, OR, SE
1209  2019 AMCP Partnership Forum: Building the Foundation for Patient-Reported Outcomes-Infrastructure and Methodologies. AMCP
1210  2019 An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. FACT-B, HRQoL
1211  2019 Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification. CCA, FDA, MI, QOL
1212  2019 Anterior and Rotational Knee Laxity Does Not Affect Patient-Reported Knee Function 2 Years After Anterior Cruciate Ligament Reconstruction. ACL, IKDC
1213  2019 Anterior Cruciate Ligament Reconstruction With Hamstring Autograft: A Matched Cohort Comparison of the All-Inside and Complete Tibial Tunnel Techniques. ACL, ACLR, IKDC
1214  2019 Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma. CSS, NARES, TSS-PROs
1215  2019 Applying a value-based care framework to post-mastectomy reconstruction. ---
1216  2019 Applying PRO Reference Values to Communicate Clinically Relevant Information at the Point-of-care. ---
1217  2019 Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review. ---
1218  2019 Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study. BBDC, PRO, PROMIS, RDCRN
1219  2019 Assessing RA Disease Activity with PROMIS Measures using Digital Technology. CAT
1220  2019 Assessment of Association Between Spino-Pelvic Parameters and Outcomes Following Gluteus Medius Repair. SVA
1221  2019 Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. GI, OS-MMAS, PMO, QOL, TSQM
1222  2019 Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis. allo-SCT, MF, MPN-SAF, QOL
1223  2019 Association between disease-specific anxiety at discharge and functional outcome in patients after total knee arthroplasty. KSS, TKA
1224  2019 Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy. AUC, ORTs, QOL, ROC
1225  2019 Blinding and Patient-Reported Outcome Completion Rates in US Food and Drug Administration Cancer Trial Submissions, 2007-2017. FDA
1226  2019 Burden of disease in patients with chronic hepatitisC in the Austrian REAL study. CHC, CP, DSV, EQ-5D-5L, SVR12
1227  2019 Burst Spinal Cord Stimulation: A Systematic Review and Pooled Analysis of Real-World Evidence and Outcomes Data. SCS
1228  2019 CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice. CANA, CHES-Q, SBP, T2DM
1229  2019 Cancer survivor perspectives on sharing patient-generated health data with central cancer registries. PGHD
1230  2019 Challenges in the Pathophysiology, Diagnosis and Management of Intestinal Fibrosis in Inflammatory Bowel Disease. CD, IBD, IOIBD
1231  2019 Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis. axSpA, ECM, MMP, nr, PGDA
1232  2019 Children with Enthesitis Have Worse Quality of Life, Function, and Pain, Irrespective of their Juvenile Arthritis Category. CHAQ, ERA, JAQQ, JIA, QoML, ReACCh-Out, VAS
1233  2019 Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry. CHE
1234  2019 Clinical factors associated with the overuse of asthma rescue medication. ACQ-5, HURM, LURM, TAI
1235  2019 Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology. QOL
1236  2019 Comparing Nipple-sparing Mastectomy to Secondary Nipple Reconstruction: A Multi-institutional Study. IBBR, NSM, SNR
1237  2019 Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients. axSpA, RA
1238  2019 Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome. AO, BCT, BT, EBRT, QOL
1239  2019 Comparison of Outcomes Following Anterior vs Posterior Fusion Surgery for Patients With Degenerative Cervical Myelopathy: An Analysis From Quality Outcomes Database. LOS, mJOA, NDI, NRS, QOD, RTW
1240  2019 Comparison of Postoperative Outcomes Between Primary MIS TLIF and MIS TLIF With Revision Decompression. LD
1241  2019 Comparison of Stand-alone Lateral Lumbar Interbody Fusion versus Open Laminectomy and Posterolateral Instrumented Fusion in the Treatment of Adjacent Segment Disease following Previous Lumbar Fusion Surgery. ASD, LL, LLIF, PLF, VAS
1242  2019 Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry. AMR, ePRO, QOL
1243  2019 Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study). EQ-5D-5L, OR, RRMM
1244  2019 Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. COPRAC, HCPs, US
1245  2019 Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. IBS
1246  2019 Current state of quality of life and patient-reported outcomes research. ---
1247  2019 Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. BDI-II, CHC, CLDQ-HCV, FACIT-F, FSS, SF-36, SVR
1248  2019 Defining and Optimizing Value in Total Joint Arthroplasty From the Patient, Payer, and Provider Perspectives. OR, TJA
1249  2019 Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study. FVC, ILD, IPF
1250  2019 Development of a novel patient-reported measure for acromegaly: the Acro-TSQ. Acro-TSQ, CE, SSAs
1251  2019 Development of Deployable Predictive Models for Minimal Clinically Important Difference Achievement Across the Commonly Used Health-related Quality of Life Instruments in Adult Spinal Deformity Surgery. ASD, MAE
1252  2019 Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer. GMH, GPH, PROMIS
1253  2019 Do Female Athletes Return to Sports After Hip Preservation Surgery for Femoroacetabular Impingement Syndrome?: A Comparative Analysis. BMI, FAIS, HOS-ADL, HOS-SS, MCID, mHHS, PASS, VAS
1254  2019 Do Femoral Head Osteochondral Lesions Predict a Poor Outcome in Hip Arthroscopy Patients? A Matched Control Study With Minimum 5-Year Follow-Up. FH, VAS
1255  2019 Does Neck Disability Index Correlate With 12-Month Satisfaction After Elective Surgery for Cervical Radiculopathy? Results From a National Spine Registry. ASA, DCR, NDI
1256  2019 Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. AD, DLQI, HADS, NRS, POEM, QOL, SCORAD
1257  2019 Early results of augmented anatomic glenoid components. ROM, TSAs
1258  2019 Effect of alcohol consumption on patient-reported outcomes in hip arthroscopy: a matched controlled study with minimum 2-year follow-up. ---
1259  2019 Effect of Cigarette Smoking on Patient-Reported Outcomes in Hip Arthroscopic Surgery: A Matched-Pair Controlled Study With a Minimum 2-Year Follow-up. HOS-SSS, iHOT-12, mHHS, NAHS
1260  2019 Effect of marital status on patient-reported outcomes following total hip arthroplasty: a matched analysis with minimum 2-year follow-up. BMI
1261  2019 Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies. AEs, CAT, FEV1, ICS, SAEs, SGRQ, TDI
1262  2019 Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies. IND/GLY
1263  2019 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond. ASQoL, BP, EQ-5D-3L, FACIT-Fatigue, PCS, PF, PGJS, PsA, PtGA, RP, SF, SF-36v2, TNFi-IR
1264  2019 Effects of surgery on the patient-reported outcomes of primary hyperparathyroidism patients with mild hypercalcemia without classic symptoms: a systematic review of the literature. QOL
1265  2019 Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2). AD, HRQoL
1266  2019 Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis. AEs, DAAs, G/P, HCV
1267  2019 Electronic Image Documentation of Patient Reported Outcomes Using Mobile Technologies. ---
1268  2019 Evaluating Patient-Reported Outcomes in Inguinal Hernia Clinical Trials. CONSORT
1269  2019 Evaluating the Concurrent Validity of PROMIS Physical Function in Anterior Cervical Discectomy and Fusion. ACDF, NDI, PF, PROMIS, SF-12, VAS
1270  2019 Evaluation of two frailty indices, with practical application in a vaccine clinical trial. FIs, PF, RZV, SF-36
1271  2019 Expert Consensus on Screening and Assessment of Cognition in Psychiatry. NPDs
1272  2019 Exploratory analysis of treatment response trajectories in the PRISM trial: Models of psychosocial care. AYAs, MCIDs, PRISM, UC
1273  2019 Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis. axSpA, BASFI, TNFi
1274  2019 Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). HRQoL, OAB, OAB-q SF, TEAE
1275  2019 Feasibility and acceptability of a psychosocial and adherence electronic patient reported outcomes (PROs) system at an HIV care center in southern India. LMICs
1276  2019 First Report of a Multiphase Pilot to Measure Patient-Reported Outcomes in the American College of Surgeons National Surgical Quality Improvement Program. ACS-NSQIP
1277  2019 First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials. LTRs, NSCLC, PFS
1278  2019 Five-Year Outcomes and Return to Sport of Runners Undergoing Hip Arthroscopy for Labral Tears With or Without Femoroacetabular Impingement. VAS
1279  2019 Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. ADLs, CI, HE, HRQoL, ICT, IQR, MELD-Na, OR, PSQI
1280  2019 Generic and psychological patient-reported deficits in those with chronic ankle instability: A cross sectional study. ---
1281  2019 Geographical variations in patient-reported outcomes after total hip arthroplasty between 2008 - 2012. HRQoL, THA
1282  2019 Glenoid component lucencies are associated with poorer patient-reported outcomes following anatomic shoulder arthroplasty. MCID, TSA
1283  2019 Going beyond Activity and Participation: Development of the DIF-CHUM-A patient-reported outcome measure for individuals with Dupuytren's contracture. DC, DIF-CHUM
1284  2019 Health Outcomes for Definite Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study. ---
1285  2019 Health-related quality of life, psychosocial functioning, and unmet health needs in patients with sarcoma: A systematic review. HRQoL
1286  2019 Healthcare provision, functional ability and quality of life after proximal femoral fracture - 'ProFem': Study protocol of a population-based, prospective study based on individually linked survey and statutory health insurance data. PFF, SHI
1287  2019 Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China. CHC, DAAs, HCV, PR
1288  2019 How much do calcitonin gene-related peptide monoclonal antibodies improve the quality of life in migraine? A patient's perspective. CGRP-mABs, EMA, FDA, QOL
1289  2019 Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies. HRQoL, RCTs, SLE
1290  2019 Impact of Contralateral Symmetry Procedures on Long-Term Patient-Reported Outcomes following Unilateral Prosthetic Breast Reconstruction. BR, CSP, HRQoL
1291  2019 Impact of Iliac Crest Bone Grafting on Postoperative Outcomes and Complication Rates Following Minimally Invasive Transforaminal Lumbar Interbody Fusion. BMP-2, ICBG, MCID, ODI, VAS
1292  2019 Impact of missing data on bias and precision when estimating change in patient-reported outcomes from a clinical registry. CCA, CI, MI, ML, RMSE
1293  2019 Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry. BSA, DLQI, EQ-VAS, IGA, WPAI
1294  2019 Impact of severe hypoglycaemia on psychological outcomes in adults with Type 2 diabetes: a systematic review. ---
1295  2019 Implementation of Value Based Breast Cancer Care. EHR, IPU, VBHC
1296  2019 Implementation of Value-based Medicine (VBM) to Patients With Chronic Hepatitis C (HCV) Infection. HRQoL, VBM
1297  2019 Implementing patient-reported outcomes in clinical decision-making within knee and hip osteoarthritis: an explorative review. PROMs
1298  2019 Improved patient-reported outcomes after autologous fat transplantation and corrective surgery after breast surgery. AFT, HRQoL, SSQ
1299  2019 Improvement in Back and Leg Pain and Disability Following Adult Spinal Deformity Surgery: Study of 324 Patients With 2-year Follow-up and the Impact of Surgery on Patient-reported Outcomes. ASD, NRS, ODI, PT, SRS, SVA, TK
1300  2019 Improvements in Grip and Pinch Strength and Patient-reported Outcomes After Anterior Cervical Discectomy and Fusion. ACDF, ROC
1301  2019 Improvements in productivity and increased participation in daily activities over 52weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study. AEs, CZP, RA
1302  2019 Improving perioperative pain management: a preintervention and postintervention study in 7 developing countries. IASP, PIs, QI
1303  2019 Increasing reoperation rates and inferior outcome with prolonged symptom duration in lumbar disc herniation surgery - a prospective cohort study. EQ-5D, LDH, ODI, VAS
1304  2019 Independent Correlation of the C1-2 Cobb Angle With Patient-Reported Outcomes After Correcting Chronic Atlantoaxial Instability. AAI, JOA, LMS, NDI, PS, SF-36 PCS, TLS
1305  2019 Influence of response shift and disposition on patient-reported outcomes may lead to suboptimal medical decisions: a medical ethics perspective. ---
1306  2019 Interpreting and Acting on the PRO Scores From the Patient-reported Outcomes for Personalized Treatment and Care (PROMPT-Care) eHealth System. ---
1307  2019 Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks. IR, PBO, PsA, TNFi
1308  2019 JAAD Game Changers: Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). AD
1309  2019 Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials. ---
1310  2019 Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America. CU, UCT
1311  2019 Lessons learned while integrating patient-reported outcomes in a psychiatric hospital. ---
1312  2019 Linking Practice Adoption of Patient Engagement Strategies and Relational Coordination to Patient-Reported Outcomes in Accountable Care Organizations. ACOs, CVD, PAM
1313  2019 Long-Term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients with Chronic HCV Infection. HCV, SF-36, SVR
1314  2019 Long-term Patient-reported Outcomes Following Postmastectomy Breast Reconstruction: An 8-year Examination of 3268 Patients. ABR, IBR, PMR, QOL, SDs
1315  2019 Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. ACR, AEs, csDMARDs, DAS28, LTE, PY, RA, SAEs, TCZ
1316  2019 Lumbar spondylolisthesis: modern registries and the development of artificial intelligence. ---
1317  2019 Making a picture worth a thousand numbers: recommendations for graphically displaying patient-reported outcomes data. ---
1318  2019 Meaningful Patient-centered Outcomes 1 Year Following Cardiac Surgery. GMH, GPH, PF, PROMIS
1319  2019 Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID). FACIT, PARC, PsA, PsAID
1320  2019 Meta-analysis of patient-reported outcomes after laparoscopic versus open inguinal hernia repair. RR
1321  2019 Methods for evaluating quality of life and vision in patients undergoing lens refractive surgery. IOLs
1322  2019 Minimal clinically important difference of commonly used hip-, knee-, foot-, and ankle-specific questionnaires: a systematic review. MCID
1323  2019 Minimally-Invasive midline posterior interbody fusion with cortical bone trajectory screws compares favorably to traditional open transforaminal interbody fusion. CBT
1324  2019 Minimum 5-Year Outcomes of Arthroscopic Hip Labral Reconstruction With Nested Matched-Pair Benchmarking Against a Labral Repair Control Group. PLRECON, PLREPAIR
1325  2019 Municipality-based pragmatic rehabilitation stratified in accordance with individual needs-results from a longitudinal survey study. FACT-B, HRQoL
1326  2019 Musculoskeletal-based Patient-reported Outcome Performance Measures, Where Have We Been-Where Are We Going. ---
1327  2019 Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings. SCD
1328  2019 Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial. ASBI, LCSS, MMRMs, NSCLC, TMB, UI, VAS
1329  2019 Nonagenarians qualify for total knee arthroplasty: a report on 329 patients from the Swedish Knee Arthroplasty Register 2000-2016. OA, TKA
1330  2019 Obesity is Independently Associated With Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus. BMI, CES-D, FMI, SF-36, SLAQ, SLE
1331  2019 Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review. AQLQ, QOL
1332  2019 Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology. FDA, NEI, PFDD
1333  2019 Outcomes of Hip Arthroscopic Surgery in Adolescents With a Subanalysis on Return to Sport: A Systematic Review. HOS-ADL, HOS-SSS, mHHS, NAHS, VAS
1334  2019 Outcomes of Nonoperative Management, Iliopsoas Tenotomy, and Revision Arthroplasty for Iliopsoas Impingement after Total Hip Arthroplasty: A Systematic Review. IP, IPI, THA
1335  2019 Outcomes of Revision Hip Arthroscopic Surgery: A Systematic Review and Meta-analysis. HOS-ADL, mHHS, VAS
1336  2019 Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. ABC, HR, PFS
1337  2019 Patellar tendon shortening following patellofemoral joint replacement. PFJR, QOL
1338  2019 Patient Demographic and Surgical Factors that Affect Completion of Patient-Reported Outcomes 90 Days and 1 Year After Spine Surgery: Analysis from the Michigan Spine Surgery Improvement Collaborative (MSSIC). MSSIC
1339  2019 Patient reported outcome data as performance indicators in surgically treated lung cancer patients. DLCR, EORTC, GHS, RF
1340  2019 Patient Reported Outcomes after Surgery for Lumbar Disk Herniation, a Randomized Controlled Trial Comparing the Effects of Referral to Municipal Physical Rehabilitation Versus no Referral. ---
1341  2019 Patient reported outcomes associated with surgical intervention for breast cancer. BCT, MR
1342  2019 Patient reported outcomes can improve performance status assessment: a pilot study. ---
1343  2019 Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology. ---
1344  2019 Patient understanding, expectations, outcomes, and satisfaction regarding surgical management of shoulder instability. ---
1345  2019 Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within arandomized controlled trial. GI, RCT, RT
1346  2019 Patient-Reported and Functional Outcomes After Revision Amputation and Replantation of Digit Amputations: The FRANCHISE Multicenter International Retrospective Cohort Study. DASH, MHQ, PROMIS
1347  2019 Patient-reported outcome measures among breast cancer survivors: A cross-sectional comparison between Malaysia and high-income countries. HICs, ICHOM
1348  2019 Patient-reported outcome measures for acute and chronic pain: current knowledge and future directions. COSs, PROMs
1349  2019 Patient-Reported Outcome Measures for Adult Dental Patients: A Systematic Review. dPROMs
1350  2019 Patient-reported outcome measures in subarachnoid hemorrhage: A systematic review. aSAH, COSMIN, PROMs, SS-QOL
1351  2019 Patient-reported outcomes (PROs) as a routine measure for cancer inpatients: the final missing piece of the puzzle? ---
1352  2019 Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study. DLCR, EORTC
1353  2019 Patient-reported outcomes 1 to 5 years after ACL reconstruction: effect of combined injury, and associations with MRI-defined osteoarthritis features. ACLR, BMLs, IKDC, KOOS, QOL
1354  2019 Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. IGC
1355  2019 Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study. GHS, HRQoL, mCRC
1356  2019 Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108. BLCS, EORTC, FACT-Bl, HRQoL, mUC, NLR, QLQ-C30, SD, TOI
1357  2019 Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors. ALND, LE, SN
1358  2019 Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States. PASI
1359  2019 Patient-reported outcomes as predictors of survival in patients with bowel cancer: a systematic review. CRC, OS, PFS
1360  2019 Patient-reported outcomes assessment tools for use in psoriasis in Spain: A systematic review. HRQoL
1361  2019 Patient-Reported Outcomes for Cancer Patients Receiving Checkpoint Inhibitors: Opportunities for Palliative Care-A Systematic Review. HRQoL, ICIs
1362  2019 Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. T2D
1363  2019 Patient-reported outcomes in Alberta: rationale, scope, and design of a database initiative. ---
1364  2019 Patient-Reported Outcomes in AtrialFibrillation Research: Results of a Clinicaltrials.gov Analysis. AF, AFEQT
1365  2019 Patient-Reported Outcomes in Cardiothoracic Surgery. ---
1366  2019 Patient-Reported Outcomes in Health Economic Decision-Making: A Changing Landscape in Oncology. ---
1367  2019 Patient-reported outcomes in lasers and light therapy. PROMs
1368  2019 Patient-reported outcomes in light of supportive medications in treatment-naive lung cancer patients. MDASI
1369  2019 Patient-reported outcomes in lung and esophageal cancer. HRQoL
1370  2019 Patient-Reported Outcomes in Oncology, Beyond Randomized Controlled Trials. ---
1371  2019 Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication. ---
1372  2019 Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review. BC, RCTs
1373  2019 Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores. ---
1374  2019 Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia. CP-CML, EQ-5D, FACT-Leu, HRQoL, mITT
1375  2019 Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy. ---
1376  2019 Patient-Reported Outcomes Measurement Information System Versus Legacy Instruments: Are They Ready for Prime Time? PROMIS
1377  2019 Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD. CCQ, FDC, ICS, LABA, LAMA, LCADL, PSM, WPAI
1378  2019 Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial. FACT-G, FKSI-19, HR, HRQoL, VAS
1379  2019 Patient-Reported Outcomes Predict Mortality in Lupus. CES-D, SF-36, SLE
1380  2019 Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities. CAR-T, HRQoL, PROMIS
1381  2019 Patient-Reported Outcomes with PD-1/PD-L1 Inhibitors for Advanced Cancer: A Meta-Analysis. CI, QLQ-C30, RCTs, TTD
1382  2019 Patient-Reported Outcomes: Understanding Surgical Efficacy and Quality from the Patient's Perspective. ---
1383  2019 Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF. ACTS, TSQM-II
1384  2019 Patient-Reported Satisfaction Following Radiation of Implant-Based Breast Reconstruction. IBR, PMRT
1385  2019 Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study. DAA, HCV, MIC, SVR
1386  2019 Patients undergoing hip arthroscopy with active workers' compensation claims do not demonstrate inferior outcomes at mid-term. BMI, RTW, VAS, WC
1387  2019 Patients' views on routine collection of patient-reported outcomes in rheumatology outpatient care - a multicenter focus group study. IA
1388  2019 Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region. MENA
1389  2019 Payer type does not impact patient-reported outcomes after primary total knee arthroplasty. KOOS-Jr, TKA, VR-12
1390  2019 Performance of the PROMIS After Operative Interventions for Shoulder Instability. ASES, Marx, PROMIS, WOSI
1391  2019 Personalized Health Systems-Past, Present, and Future of Research Development and Implementation in Real-Life Environment. EHRs, HMOs, PGD, PHS, QOL
1392  2019 Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study. RA
1393  2019 Pilot randomized trial of an electronic symptom monitoring and reporting intervention for hospitalized adults undergoing hematopoietic stem cell transplantation. HCT
1394  2019 Polytrauma and High-energy Injury Mechanisms Are Associated with Worse Patient-reported Outcomes After Distal Radius Fractures. CI, HRQoL, ISS
1395  2019 Postoperative satisfaction following lumbar spinal fusion surgery: patient expectation versus actuality. MIS, ODI, VAS
1396  2019 Predicting patient-reported outcomes following hip and knee replacement surgery using supervised machine learning. VAS
1397  2019 Predictive factors for satisfaction after contemporary unicompartmental knee arthroplasty and high tibial osteotomy in isolated medial femorotibial osteoarthritis. HTO, OA, UKA
1398  2019 Predictors of Patient-Reported Outcomes at 2 Years After Revision Anterior Cruciate Ligament Reconstruction. ACL, IKDC, KOOS
1399  2019 Predictors of Persistent Postoperative Pain at Minimum 2 Years After Arthroscopic Treatment of Femoroacetabular Impingement. FAIS
1400  2019 PROMIS Physical Function for prediction of postoperative pain, narcotics consumption, and patient-reported outcomes following minimally invasive transforaminal lumbar interbody fusion. ODI, PROMIS PF, VAS
1401  2019 Promising early outcomes of a novel anatomic knee system. TKA
1402  2019 Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy. NAC, RC
1403  2019 PROs in the wild: Assessing the validity of patient reported outcomes in an electronic registry. ---
1404  2019 Prospective longitudinal cohort study of patient recovery after major gastrointestinal surgery: is there a difference between minimally invasive and open approaches? AUC, MIS
1405  2019 Prospective observational study in patients with obstructive lung disease: NOVELTY design. COPD, HCU
1406  2019 Prospective, Randomized Control Trial Investigating the Impact of a Physician-Communicated Radiation Therapy Plan Review on Breast Cancer Patient-Reported Satisfaction. OS, PC, RT, SD, TC
1407  2019 Provider perspectives on the integration of patient-reported outcomes in an electronic health record. EHRs
1408  2019 Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. HRQoL
1409  2019 Quality of life outcomes in patients presenting for evaluation of CNS tumors. ECOG, PROMIS
1410  2019 Reconsidering the minimally important difference: evidence of instability over time and across groups. GAC, MID, QOL
1411  2019 Recruitment via social media: advantages and potential biases. AYA, EMR
1412  2019 Reduced Patient-Reported Outcome Scores Associate with Level of Fibrosis in Patients with Nonalcoholic Steatohepatitis. ---
1413  2019 Relationship Between Baseline Patient-reported Outcomes and Demographic, Psychosocial, and Clinical Characteristics: A Retrospective Study. HOOS/KOOS, ORs, PCS, MCS, TJR, VR-12
1414  2019 Relationship Between the Patient-Reported Outcome Measurement Information System and Traditional Patient-Reported Outcomes for Osteoarthritis. CAT, HOOS-JR, KOOS-JR, PROMIS
1415  2019 Relevance of Th2 markers in the assessment and therapeutic management of severe allergic asthma: a real life perspective. ---
1416  2019 Reliability of the Neck Disability Index and Japanese Orthopedic Association questionnaires in adult cervical radiculopathy and myelopathy patients when administered by telephone or via online format. ICCs, JOA, NDI
1417  2019 Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease. SSc-ILD
1418  2019 Religion and spirituality as predictors of patient-reported outcomes in adults with congenital heart disease around the globe. ---
1419  2019 Reporting of late morbidity after radiotherapy in large prospective studies: A descriptive review of the current status. CONSORT
1420  2019 Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. FSAD, FSD, FSDS-DAO, HSDD, MCID, ROC
1421  2019 Response rate and costsforautomated patient-reported outcomes collection alone compared to combined automated and manual collection. ACLR, PROMs
1422  2019 Response Shift After a 4-Week Multimodal Intervention for Chronic Ankle Instability. CAI, RS
1423  2019 Review: Patient-reported outcomes in multiple sclerosis care. MS
1424  2019 Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study. 6MWD, LPH, PAH, SD, WHO-FC
1425  2019 Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-Reported Outcomes Following Anterior Cervical Discectomy and Fusion. ACDF, CCI, MCID, NDI, VAS
1426  2019 Safety of 2-level Anterior Cervical Discectomy and Fusion (ACDF) Performed in an Ambulatory Surgery Setting With Same-day Discharge. ACDF, ASCs
1427  2019 Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial. CIPN, TENS
1428  2019 Sexual Function in Women with Colorectal/Anal Cancer. ---
1429  2019 Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the "APAD1" randomized controlled trial. APAD, BMI, QOL, UC
1430  2019 Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. EQ-VAS, MDADI, MDASI-HN-S, OPC, QOL
1431  2019 Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension. NOH, QOL
1432  2019 Spinal Instability Neoplastic Score component validation using patient-reported outcomes. SINS
1433  2019 Subgroup Differences and Determinants of Patient-Reported Mental and Physical Health in Patients With Ischemic Heart Disease: Results From the DenHeart Study. IHD, non-STEMI, STEMI
1434  2019 Survival, Complications and Patient Reported Outcomes after Pancreatic Surgery. CCI, CD, PDAC
1435  2019 Symptom-based patient-reported outcomes in adults with eosinophilic esophagitis: value for treatment monitoring and randomized controlled trial design. EoE
1436  2019 Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials. ---
1437  2019 Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial. CI, HR, IMDC, ORR, OS, PFS, TemPa, VEGFR-TKI
1438  2019 The association of physical activity and depression in patients with, or at risk of, osteoarthritis is captured equally well by patient reported outcomes (PROs) and accelerometer measurements - Analyses of data from the Osteoarthritis Initiative. ACCs, AUC, OA, PA, PASE, PMSC
1439  2019 The China Patient-centred Evaluative Assessment of Cardiac Events (PEACE) prospective heart failure study design. HF, PEACE
1440  2019 The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. EQ5D3L, FACIT-F, HADS, HRQoL, MES, SIBDQ, UC, WPAI
1441  2019 The COMFORT Cohort: Identifying Biomarkers Relevant to Functional Gastrointestinal Disorders (P20-039-19). GI, IBS, PROMIS, SAGIS
1442  2019 The Effect of Complete Tearing of the Ligamentum Teres in Patients Undergoing Primary Hip Arthroscopy for Femoroacetabular Impingement and Labral Tears: A Match-Controlled Study. FAI, HOS-SSS, iHOT-12, LT, mHHS, NAHS, THA, VAS
1443  2019 The Effect of Payer Type on Patient-Reported Outcomes in Total Joint Arthroplasty Is Modulated by Baseline Patient Characteristics. TJA
1444  2019 The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion. DOS, MCID, ODI, VAS
1445  2019 The Effect of Symptom Duration on Outcomes After Fusion for Degenerative Spondylolisthesis. EQ-5D, ODI, QOD
1446  2019 The Effect of Tobacco Use on Postoperative Pain Following Anterior Cervical Discectomy and Fusion. ACDF, VAS
1447  2019 The influence of radiographic markers of biomechanical variables on outcomes in reverse shoulder arthroplasty. AHI, AI, COR, CSA, DLA, ROM
1448  2019 The intra-meatal application of alprostadil cream (Vitaros) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial. AEs, ED, PSAE
1449  2019 The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. FGF23, XLH
1450  2019 The PROMIS Upper Extremity Computer Adaptive Test Correlates With Previously Validated Metrics in Patients With Carpal Tunnel Syndrome. BCTQ, CTS, PROMIS UE, Q-DASH
1451  2019 The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis. AS, CRP
1452  2019 The role of exercise in improving patient-reported outcomes in individuals on dialysis: A scoping review. ---
1453  2019 The role of illness uncertainty in the relationship between disease knowledge and patient-reported outcomes among adolescents and adults with congenital heart disease. CHD, HRQoL
1454  2019 The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. QOL
1455  2019 The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. OGC, PC, REDCap, UGICR
1456  2019 The Use of Patient-Reported Outcome Measures: Secondary School Athletic Trainers' Perceptions, Practices, and Barriers. ATs
1457  2019 The Use of Patient-Reported Outcomes in Patients Treated With Maintenance Hemodialysis: A Perspective. ---
1458  2019 Thoracolumbar Fusion in Extreme Obesity: Complications and Patient-Reported Outcomes. ASA, BMI, CCI, ODI, VAS
1459  2019 Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen. ICBB, NSABP
1460  2019 Tobacco Smoking Independently Predicts Lower Patient-Reported Outcomes: New Insights on a Forgotten Epidemic. SF-12 PCS, TJA, WOMAC
1461  2019 Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs. ASQoL, BP, csDMARD-IR, EQ-5D-3L, FACIT-Fatigue, PCS, PF, PGJS, PsA, PtGA, SF-36v2
1462  2019 Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials. ASDD, DLQI, GT, HDSS, PGIC, WI
1463  2019 Total Ankle Arthroplasty Survival and Risk Factors for Failure. AOS, TAA
1464  2019 Total Knee Arthroplasty Outcomes in Patients with Medicare, Medicare Advantage, and Commercial Insurance. CJR, TKA
1465  2019 Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study. CAT, CCQ, COPD, FEV1, TDI
1466  2019 Turning Feed-forward and Feedback Processes on Patient-reported Data into Intelligent Action and Informed Decision-making: Case Studies and Principles. CH, D-H, SRQ
1467  2019 Type of clinical outcomes used by healthcare professionals to evaluate health-related quality of life domains to inform clinical decision making for chronic pain management. CO, CP, HCPs, HRQoL, OMs, PROMIS
1468  2019 US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry. BSA, IGA
1469  2019 Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. ePRO, MJS, PRO, RA, RCTs
1470  2019 Using qualitative research to reduce readmissions and optimize perioperative cystectomy care. mHealth
1471  2019 Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies. CDS, PRO
1472  2019 Utility of Anxiety/Depression Domain of EQ-5D to Define Psychological Distress in Spine Surgery. ---
1473  2019 Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). MIS
1474  2019 Validation of a Digital Support App to Assess Inflammatory Disease Activity and Mental Health Patient-Reported Outcomes (PROs): A Pilot Investigation. DST
1475  2019 Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease. HD
1476  2019 Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes. EDSS, ICC, ICC, MS, MSPT
1477  2019 Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C. ---
1478  2019 VITALITY: impact of adalimumab on health and disability outcomes in patients with Crohn's disease, rheumatoid arthritis, or psoriasis treated in clinical practice in New Zealand. CD, NZ, RA, WHODAS
1479  2019 What patients with Idiopathic Pulmonary Fibrosis and caregivers want - Filling the currents gaps with patient reported outcomes and experience measures. PREMs, PROMs
1480  2019 Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? RA
1481  2019 [German linguistic validation of the BODY-Q: standardised PRO instrument after bariatric and bodycontouring surgery]. ---